Quantcast
Channel: ナカライテスク
Viewing all 1104 articles
Browse latest View live

過酸化物フリーの、膜タンパク質の抽出に適した界面活性剤 Anatrace® Anapoe®グレード

$
0
0

過酸化物フリーの界面活性剤
Anatrace® Anapoe®グレード

new Anatrace Logo_RGB_web.jpg

 

 

 

 

膜タンパク質の抽出に用いられる非イオン性界面活性剤に過酸化物が含まれると、膜タンパク質を抽出する際にタンパク質の凝集や不活性化を誘導する場合があります(参考文献参照)。Anatrace Products社のAnapoe®グレードの製品は、過酸化物をほとんど含まない非イオン性界面活性剤です。

 

 

特長

  • 過酸化物濃度はすべて20μM以下
  • アルゴンガス充填でご提供
  • 取り扱い易い水溶液タイプ

 

 

参考文献
  1. Chang, H. W. Proc. Nat. Acad. Sci. USA 71, 2113-2117 (1974).
  2. O'Brien, R. D. and Gibson, R. E. ABB 169, 458-463 (1975).
  3. Chang, H. W. and Neumann, E. Proc. Nat. Acad. Sci. USA 73, 3364-3368 (1976).

 

 

価格表
 製品名メーカー
製品番号
容量価格オンライン
カタログへ

Anapoe®-20(Tween® 20)

 

CMC:0.059 mM

APT020 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800

Anapoe®-35(Brij®-35)

 

会合数:40

CMC:0.091 mM

APB035 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800

Anapoe®-58(Brij®-58)

 

CMC:0.004 mM

APB058 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800

Anapoe®-80(Tween® 80)

 

会合数:58

CMC:0.012 mM

APT080 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800

Anapoe®-C10E6

 

会合数:40

CMC:0.9 mM

APO106 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800

Anapoe®-C10E9

 

CMC:1.3 mM

APO109 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800

Anapoe®-C12E8

 

CMC:0.09 mM

APO128 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800

Anapoe®-C12E9

 

CMC:0.05 mM

APO129 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800

Anapoe®-C12E10

 

CMC:0.2 mM

AP1210 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800

Anapoe®-C13E8

 

CMC:0.1 mM

APO138 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800

Anapoe®-NID-P40(Nonidet® P40 Substitute)

 

会合数:100-155

CMC:0.05-0.3 mM  

APND40 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800

Anapoe®-X-100(Triton® X-100)

 

会合数:75-165

CMC:0.23 mM

APX100 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800

Anapoe®-X-114(Triton® X-114)

 

CMC:0.2 mM

APX114 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800

Anapoe®-X-305(Triton® X-305)

 

CMC:0.65 mM

APX305 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800

Anapoe®-X-405(Triton® X-405)

 

CMC:0.81 mM

APX405 50×1 ml 24,800 e-Nacalai.jpg
5×10 ml 20,800
10×10 ml 37,300
500 ml 149,800
Anapoe® Master Kit* DSOL-ANP10 1 kit 30,700 e-Nacalai.jpg

HPLCにて精製した界面活性剤を10%水溶液に調製しています。
*Master Kitは、上記15種類のAnapoe®グレードの界面活性が10mlずつ内包された製品です。

 

※記載の内容は、'14年5月現在の情報に基づいております。

 


Agarose Bead Technologies社 1級アミンを固定化するアガロースビーズ Glyoxal Resins

$
0
0

アガロースビーズに好みのリガンドを結合可能

ABTlogo.gif

 

 

 

 

この製品に関するご意見・ご照会・お問合せはこちら

 

 

GLYOXAL RESINS

 

Immobilization technique allows affinity ligands’ binding giving high stability and making easy to re-use the conjugated ligand. Glyoxal beads allow a covalent binding of agarose to lysine amino groups.

ABT offers a wide range of products activated with different degree of aldehydes groups and using two different backbone (4% & 6% beads) and different particle sizes. Giving adequate options to work in batch or column purifications (Glyoxal Agarose Beads for Low Pressure applications) and large scale process (Glyoxal Rapid Run™ for High Pressure applications).

 

ABT Glyoxal resins allow a covalent binding of agarose to amino groups of ligands (antibodies, antigens, enzymes, proteins or other biomolecules). The aldehyde groups (resin) react with exposed primary amines (biomolecul). The result of the biomolecule immobilization is a stable and reusable resin for affinity purification in batch, spin column or gravity procedures.

 

 

COUPLING LIGAND

Ligand: antibody, antigen, enzyme, affinity proteins (e.g. Protein A or Protein G) or biomolecule.

 

 

FEATURE

  • Binding through Lys zones: reproducible process
  • Very stable ligand binding (covalent )
  • High ligand binding capacity
  • High specificity (no cations present)
  • Quick ligand conjugation
  • No affinity ligand loss (reusable)
  • Ready to use
  • Long shelf- life (expiration 5 years)

 

 

Low Pressure: GLYOXAL Agarose Beads

Bead (Geometry, size) Spherical, Standard: ~50 - 150µm
Cross-Linked Yes
Matrix Active Groups Agarose with some diols oxidized to aldehydes
Product Name VERY HIGH Density GLYOXAL 4BCL VERY HIGH Density GLYOXAL 6BCL HIGH Density GLYOXAL 4BCL HIGH Density GLYOXAL 6BCL LOW Density GLYOXAL 4BCL LOW Density GLYOXAL 6BCL
Agarose % 4 6 4 6 4 6
Activation Degree (µmol Glyoxyl/ml gel) - 80-100 40-60 40-60 15-25 15-25
Binding Capacity(1) (mg BSA/ml gel) - 25-30 15-20 20-25 5-10 5-10
Cat. No. - 6BCL-GH1-X* 4BCL-GH1-X* 6BCL-GM3-X* 4BCL-GH0-X* 6BCL-GH0-X*
Antimicrobial Agent 0.5M NaCL containing 0.02% thimerosal or 20% ethanol
Storage Temperature 2-8℃

 

*X: Product Quantity

 

 

 

 High Pressure: GLYOXAL Rapid Run™ Beads

Bead (Geometry, size) Spherical, Standard: ~50 - 150µm Spherical, Fine: ~20 - 50µm
Cross-Linked Highly cross-linked agarose
Matrix Active Groups Agarose with some diols oxidized to aldehydes
Product Name High Density GLYOXAL 4 RAPID RUNTM High Density GLYOXAL 6 RAPID RUNTM LOW Density GLYOXAL 4 RAPID RUNTM LOW Density GLYOXAL 6 RAPID RUNTM High Density GLYOXAL 4 RAPID RUNTM FINE High Density GLYOXAL 4 RAPID RUNTM 5 atoms High Density GLYOXAL 6 RAPID RUNTM FINE
Agarose % 4 6 4 6 4 4 6
Activation Degree (µmol Glyoxyl/ml gel) 40-60 40-60 15-25 15-25 15-25 ~15 15-25
Cat. No. 4RR-GH1-X* 6RR-GM3-X* 4RR-GL0-X* 6RR-GL0-X* 4RRF-GL0-X* 4BRRF-5L-X* 6RRF-GL0-X*
Antimicrobial Agent 20% Ethanol
Storage Temperature 2-8℃

 

*X: Product Quantity (25 or 100ml)

 

 

この製品に関するご意見・ご照会・お問合せはこちら

InvivoGen社 細胞質内DNAセンサーSTING研究用試薬

$
0
0

InvivoGen社 細胞質内DNAセンサーSTING研究用試薬

InvivoGen社は自然免疫研究用試薬で高い評価を受けているメーカーです。細胞質内DNAセンサーとして知られているSTING研究用の製品を紹介します。

 

468_1.jpg

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

STINGは、dsDNAの刺激によりTBK1とIRF3を活性化しI型インターフェロンの発現を誘導するアダプタータンパク質です。一方でSTINGが環状ジヌクレオチド(CDN)と直接結合することで、I 型インターフェロンを誘導することも知られています。

 

 

製品カテゴリー

■STING レポーターアッセイ用細胞

STING遺伝子をノックアウトまたはノックダウンした細胞を取り揃えています。野生型と比較することでアッセイをすることができます。

■変異型STING発現プラスミド

ヒトまたはマウスの変異型 STINGを発現するプラスミドです。

■STINGリガンド

STINGを刺激してインターフェロンの発現を誘導するリガンドで、2種類のグレードからお選びいただけます。

 

 

STINGレポーターアッセイ用細胞

STING遺伝子をノックアウトまたはノックダウンしたレポーターアッセイ用細胞を販売しています。この細胞は、IRF誘導性プロモーターにより制御されているSEAP(分泌型アルカリホスファターゼ)もしくはLucia®(ルシフェラーゼ)が組み込まれています。分泌されたSEAP、Lucia®は、検出試薬であるQUANTI-Blue™ もしくは QUANTI-Luc™を用いて簡単に検出することができます。 

 

 

実施例

■THP1-Blue™ ISG 細胞とTHP1-Blue™ ISG-KD-STING 細胞のリガンドに対する応答

468_2.jpg

 

両細胞を50 μg/ml CDNsまたは104 IU/ml hIFN-βにより刺激し、24時間インキュベーションした後、SEAPをQUANTI-Blue™を用いて定量した。

 

 

■B16-Blue™ ISG 細胞とB16-Blue™ ISG-KO-STING 細胞のリガンドに対する応答

468_3.jpg

 

両細胞を30 μg/ml CDNsまたは103 U/ml mIFN-βにより刺激し、24時間インキュベーションした後、SEAPをQUANTI-Blue™を用いて定量した。

 

 

■RAW-Lucia™ ISG 細胞とRAW-Lucia™ ISG-KO-STING 細胞のリガンドに対する応答

468_4.jpg

 

両細胞を30 μg/ml CDNsまたは103 U/ml mIFN-βにより刺激し、24時間インキュベーションした後、Lucia®をQUANTI-Luc™を用いて定量した。

 

 

価格表

各製品にはZeocin™、Normocin™、アッセイ用の基質(QUANTI-Blue™またはQUANTI-Luc™)が含まれています。
本製品はお手元に到着次第、直ぐに培養する必要があります。

 

由来:THP1単球細胞(ヒト)  レポーター:SEAP
製品名メーカー製品番号容量価格オンライン
カタログへ
THP1-Blue™ ISG Cells thp-isg 3-7×106cells 221,000 e-Nacalai.jpg
THP1-Blue™ ISG-KD-STING Cells thp-kdstg 3-7×106cells 252,000 e-Nacalai.jpg
由来:HEK293細胞(ヒト)  レポーター:SEAP
製品名メーカー製品番号容量価格
HEK-Blue™ ISG Cells hkb-isg 3-7×106cells 近日発売
HEK-Blue™ ISG-KO-STING Cells hkb-kostg 3-7×106cells 近日発売
由来:B16メラノーマ細胞(マウス)  レポーター:SEAP
製品名メーカー製品番号容量価格オンライン
カタログへ
B16-Blue™ ISG Cells bb-ifnabg 3-7×106cells 249,000 e-Nacalai.jpg
B16-Blue™ ISG-KO-STING Cells bb-kostg 3-7×106cells 274,000 e-Nacalai.jpg
RAW 264.7マクロファージ(マウス)  レポーター:Lucia
製品名メーカー製品番号容量価格オンライン
カタログへ
RAW-Lucia™ ISG Cells rawl-isg 3-7×106cells 227,000 e-Nacalai.jpg
RAW-Lucia™ ISG-KO-STING Cells rawl-kostg 3-7×106cells 274,000 e-Nacalai.jpg

▲製品カテゴリーへ

 

 

変異型STING発現プラスミド

CDNの認識やシグナル伝達に影響を与えるいくつかの変異型STINGがヒトおよびマウスで報告されています。InvivoGen社では、これら変異型STINGを発現ベクター(pUNO1)へ組み込んだ状態で販売しています。

 

 

製品情報

■変異導入部位

赤字:変異アミノ酸

 

ヒト由来
製品名アミノ酸番号参考文献
71162200230232293
hSTING-WT R S I G R R -
hSTING-H232 R S I G H R 1,2
hSTING-A230 R S I A R R 1
hSTING-HAQ H S I A R Q 1,3
hSTING-A162 R A I G R R 4,5
hSTING-MRP R S I G R - 6
hSTING-N200 R S N G R R 7,8
マウス由来
製品名アミノ酸番号参考文献
70161199229231292
mSTING-WT C S I I R R -
mSTING-Gt C S N I R R 8

 

 

■ベクターマップ

468_5.jpg

 

 

性能評価

■変異型STINGのCDNsおよびDMXAAに対する応答

468_6.jpg

 

HEK- Blue™ ISG KO-STING細胞にSTING WTもしくはSTING変異体をトランスフェクションし、その細胞を、10 μg/ml 2’3’-cGAMP、3’3’-cGAMP、c-di-GMPもしくはDMXAAにより刺激した。24時間インキュベーション後、SEAPの量をQUANTI-Blue™を用いて定量した。

 

 

参考文献
  1. Yi, G. et al. Single Nucleotide Polymorphisms of Human STING Can Affect Innate Immune Response to Cyclic Dinucleotides. PLoS One. 8(10), e77846 (2013).
  2. Diner, EJ. et al. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep. 3(5), 1355-1361 (2013).
  3. Jin, L. et al. Identification and characterization of a loss-of-function human MPYS variant. Genes Immun. 12(4), 263-269 (2011).
  4. Gao, P. et al. Structure-function analysis of STING activation by c[G(2',5')pA(3',5')p] and targeting by antiviral DMXAA. Cell. 154(4), 748-762 (2013).
  5. Conlon, J. et al. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid. J Immunol. 190(10), 5216-5225 (2013).
  6. Chen, H. et al. An Alternative Splicing Isoform of MITA Antagonizes MITA-Mediated Induction of Type I IFNs. J Immunol. 192(3), 1162-1170 (2014).
  7. Yin, Q. et al. Cyclic di-GMP sensing via the innate immune signaling protein STING. Mol Cell. 46(6), 735-745 (2012).
  8. Sauer, JD. et al. The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect Immun. 79(9), 688-694 (2011).

 

 

価格表

各製品にはFast-media® BlasおよびBlasticidinが含まれています。

製品名毒劇物メーカー製品番号容量価格オンライン
カタログへ
hSTING-WT puno1-hstingwt 20 μg 90,000 e-Nacalai.jpg
hSTING-H232 puno1-hsting-h232 20 μg 96,000 e-Nacalai.jpg
hSTING-A230 puno1-hsting-a230 20 μg 96,000 e-Nacalai.jpg
hSTING-HAQ puno1-hsting-haq 20 μg 96,000 e-Nacalai.jpg
hSTING-A162 puno1-hsting-a162 20 μg 96,000 e-Nacalai.jpg
hSTING-MRP puno1-hsting-mrp 20 μg 96,000 e-Nacalai.jpg
hSTING-N200 puno1-hsting-n200 20 μg 96,000 e-Nacalai.jpg
mSTING-WT puno1-mstingwt 20 μg 90,000 e-Nacalai.jpg
mSTING-Gt puno1-msting-gt 20 μg 96,000 e-Nacalai.jpg

▲製品カテゴリーへ

 

 

STINGリガンド

スタンダードグレード(純度95%以上)とVacciGrade™(前臨床グレード:無菌条件下で製造し、エンドトキシンレベル試験済み(1EU/mg以下))を販売しています。

 

 

価格表 
製品名構造
(●をクリック)
メーカー
製品番号
容量価格オンライン
カタログへ
2’3’-cGAMP tlrl-cga23-s 500 μg 74,000 e-Nacalai.jpg
2’3’-cGAMP
VacciGrade™
vac-cga23 1 mg 166,000 e-Nacalai.jpg
3’3’-cGAMP tlrl-cga-s 500 μg 57,000 e-Nacalai.jpg
3’3’-cGAMP
VacciGrade™
vac-cga 1 mg 166,000 e-Nacalai.jpg
2’2’-cGAMP tlrl-cga22-s 500 μg 74,000 e-Nacalai.jpg
2’2’-cGAMP
VacciGrade™
vac-cga22 1 mg 166,000 e-Nacalai.jpg
c-di-AMP tlrl-cda 1 mg 48,000 e-Nacalai.jpg
c-di-AMP
VacciGrade™
vac-cda 1 mg 83,000 e-Nacalai.jpg
c-di-GMP tlrl-cdg 1 mg 50,000 e-Nacalai.jpg
c-di-GMP
VacciGrade™
vac-cdg 1 mg 83,000 e-Nacalai.jpg
c-di-IMP tlrl-cdi 1 mg 50,000 e-Nacalai.jpg
c-di-UMP tlrl-cdu 1 mg 50,000 e-Nacalai.jpg
DMXAA tlrl-dmx 5 mg 41,000 e-Nacalai.jpg

 

※記載の内容は、'14年5月現在の情報に基づいております。

 

新コンテンツ「製品使用文献」開設

Santa Cruz社 モノクローナル抗体 2014年4月新製品

$
0
0

Santa Cruz社 モノクローナル抗体 2014年4月新製品

Santa Cruz社では、シグナル中間体、転写因子など様々な研究対象のモノクローナル抗体を新発売しました。

 

 

新製品一覧

容量:200μg/ml  価格:51,000円

用途:Western Blotting, Immunoprecipitation, Immunofluorescence, ELISA

略号:Av=Avian(Bird), Bov=Bovine(Cow), Ca=Canine, Hs=Horse(Equine), Hu=Human, Ms=Mouse, Por=Porcine(Pig, Swine), Rt=Rat

製品名交差性抗原アイソタイプメーカー製品番号オンライン
カタログへ
構造タンパク質
Gelsolin (H-5) Ms, Rt, Hu 759-782 (Hu) mouse IgG1 sc-398244 e-Nacalai.jpg
HOOK1 (E-6) Hu, Ca, Bov, Por 309-354 (Hu) mouse IgG1 sc-398233 e-Nacalai.jpg
involucrin (H-8) Hu 5-28 (Hu) mouse IgG1 sc-398221 e-Nacalai.jpg
Odf3l2 (H-2) Hu 5-30 (Hu) mouse IgG2b sc-398197 e-Nacalai.jpg
TBCA (C-2) Hu 1-108 (Hu) mouse IgG1 sc-398262 e-Nacalai.jpg
TBCE (D-11) Ms, Rt, Hu 422-451 (Hu) mouse IgG1 sc-398209 e-Nacalai.jpg
合成と分解
CA V (A-1) Ms, Rt > Hu 40-69 (Ms) mouse IgG1 sc-398184 e-Nacalai.jpg
DMGDH (A-9) Hu, Rt 124-271 (Hu) mouse IgG2a sc-398256 e-Nacalai.jpg
DMGDH (C-9) Hu 124-271 (Hu) mouse IgG1 sc-398257 e-Nacalai.jpg
FAM163A (E-7) Ms, Rt, Hu 64-89 (Hu) mouse IgM sc-398152 e-Nacalai.jpg
GPAM (D-10) Hu 69-156 (Hu) mouse IgG1 sc-398135 e-Nacalai.jpg
GPIHBP1 (B-5) Hu 51-100 (Hu) mouse IgG2a sc-398175 e-Nacalai.jpg
MoCo Sulfurase (D-6) Hu 359-485 (Hu) mouse IgG2a sc-398172 e-Nacalai.jpg
NDUFB3 (F-11) Ms, Rt, Hu 12-29 (Hu) mouse IgG2a sc-398196 e-Nacalai.jpg
NDUFB3 (G-9) Ms, Rt, Hu 9-28 (Hu) mouse IgG1 sc-398174 e-Nacalai.jpg
Neuralized-2 (A-11) Hu 7-20 (Hu) mouse IgM sc-398195 e-Nacalai.jpg
神経生物学
AMBRA1 (G-6) Hu 999-1298 (Hu) mouse IgG2a sc-398204 e-Nacalai.jpg
DARPP-32 (F-2) Ms, Hu 134-195 (Bov) mouse IgG1 sc-398144 e-Nacalai.jpg
DCDC2 (B-5) Ms, Rt, Hu 330-357 (Hu) mouse IgG2b sc-398248 e-Nacalai.jpg
GRAP1 (A-6) Hu, Rt, Por 375-483 (Hu) mouse IgG2a sc-398198 e-Nacalai.jpg
GRAP1 (E-7) Hu, Rt, Por 375-483 (Hu) mouse IgG1 sc-398199 e-Nacalai.jpg
LNX2 (B-3) Ms, Hu, Ca, Av 25-52 (Hu) mouse IgG2b sc-398156 e-Nacalai.jpg
LNX2 (D-3) Ms, Hu, Ca, Av 25-52 (Hu) mouse IgG2a sc-398157 e-Nacalai.jpg
MBP (C-1) Ms, Rt, Hu 167-192 (Hu) mouse IgG2a sc-398212 e-Nacalai.jpg
SPF30 (D-11) Hu, Rt, Ca 1-152 (Hu) mouse IgG1 sc-398259 e-Nacalai.jpg
SPF30 (E-5) Hu, Ca 1-152 (Hu) mouse IgG2a sc-398258 e-Nacalai.jpg
輸送関連タンパク質
apoF (B-6) Ms 44-326 (Ms) mouse IgG1 sc-398151 e-Nacalai.jpg
COPZ1 (F-11) Ms, Rt, Hu, Hs, Ca, Bov, Por 128-159 (Hu) mouse IgG2b sc-398220 e-Nacalai.jpg
COPZ1 (H-12) Ms, Rt, Hu, Hs, Ca, Bov, Por 128-159 (Hu) mouse IgG1 sc-398219 e-Nacalai.jpg
GP73 (G-2) Ms 365-392 (Ms) mouse IgG3 sc-398230 e-Nacalai.jpg
REEP4 (H-12) Ms, Rt, Hu 174-207 (Hu) mouse IgG2a sc-398191 e-Nacalai.jpg
SCAMP1 (D-1) Ms, Rt, Hu, Ca, Por, Av 9-30 (Hu) mouse IgM sc-398154 e-Nacalai.jpg
キナーゼとホスファターゼ
ACYP2 (G-5) Hu 1-99 (Hu) mouse IgG1 sc-398251 e-Nacalai.jpg
PPP2R4 (C-10) Ms, Rt, Hu, Hs, Ca, Bov, Por, Av 172-193 (Hu) mouse IgG1 sc-398242 e-Nacalai.jpg
RPTPα (C-8) Ms, Rt, Hu, Hs, Ca, Bov, Por 194-225 (Hu) mouse IgG1 sc-398243 e-Nacalai.jpg
RPTPα (H-4) Ms, Rt, Hu, Hs, Ca, Bov, Por 178-223 (Hu) mouse IgG2a sc-398203 e-Nacalai.jpg
SgK223 (A-6) Hu 1-56 (Hu) mouse IgG1 sc-398164 e-Nacalai.jpg
SUDD (B-3) Hu 54-255 (Hu) mouse IgG1 sc-398232 e-Nacalai.jpg
腫瘍抑制因子 / アポトーシス
Bcl-G (E-10) Hu 1-300 (Hu) mouse IgG1 sc-398223 e-Nacalai.jpg
LIN-9 (C-10) Hu 259-558 (Hu) mouse IgG1 sc-398234 e-Nacalai.jpg
MCC (A-9) Hu 661-945 (Hu) mouse IgG1 sc-398216 e-Nacalai.jpg
NSD3 (E-3) Ms, Rt, Hu 1396-1420 (Hu) mouse IgM sc-398186 e-Nacalai.jpg
TGase6 (E-1) Ms, Rt, Hu, Ca 163-188 (Hu) mouse IgG1 sc-398160 e-Nacalai.jpg
シグナル中間体
Act1 (D-11) Hu 1-300 (Hu) mouse IgG1 sc-398161 e-Nacalai.jpg
Angiomotin-L2 (A-9) Hu, Ca, Bov 595-634 (Hu) mouse IgG1 sc-398261 e-Nacalai.jpg
CES1 (B-4) Hu 544-567 (Hu) mouse IgG1 sc-398236 e-Nacalai.jpg
CLN3 (C-1) Hu 13-40 (Hu) mouse IgG2b sc-398192 e-Nacalai.jpg
G6Pase-α (H-4) Ms, Rt, Hu 80-106 (Rt) mouse IgM sc-398155 e-Nacalai.jpg
HPRG (G-10) Ms, Rt, Hu, Hs 125-149 (Hu) mouse IgG2b sc-398239 e-Nacalai.jpg
HS6ST1 (C-9) Ms, Rt, Hu 52-79 (Hu) mouse IgM sc-398231 e-Nacalai.jpg
HSPA14 (G-9) Ms, Rt, Hu, Hs, Ca, Bov, Por 280-307 (Hu) mouse IgG1 sc-398208 e-Nacalai.jpg
NUBPL (G-11) Ms, Rt, Hu, Hs, Ca, Bov, Av 46-69 (Hu) mouse IgG2a sc-398217 e-Nacalai.jpg
OAS3 (D-7) Ms, Rt 2-29 (Ms) mouse IgG1 sc-398225 e-Nacalai.jpg
OPLAH (H-10) Hu 734-1013 (Hu) mouse IgG2a sc-398205 e-Nacalai.jpg
ORP150 (A-3) Ms, Rt, Hu 118-143 (Hu) mouse IgG2a sc-398224 e-Nacalai.jpg
p-Cbl (E-10) Ms, Rt, Hu, Por Tyr 700 (Hu) mouse IgM sc-377571 e-Nacalai.jpg
Peroxin 16 (H-4) Ms, Rt, Hu, Hs, Ca 281-306 (Hu) mouse IgM sc-398189 e-Nacalai.jpg
PHAX (F-1) Hu 115-189 (Hu) mouse IgG1 sc-398147 e-Nacalai.jpg
PPIL2 (D-8) Ms, Rt, Hu, Hs, Por 346-369 (Hu) mouse IgG2b sc-398200 e-Nacalai.jpg
PPIL2 (H-2) Ms, Rt, Hu, Hs, Por 346-369 (Hu) mouse IgG1 sc-398201 e-Nacalai.jpg
RGS6/7 (B-10) Ms, Rt, Hu 392-420 (Hu) mouse IgG1 sc-398222 e-Nacalai.jpg
Shc (F-7) Hu 366-473 (Hu) mouse IgG1 sc-398163 e-Nacalai.jpg
SLA2 (E-8) Hu 37-62 (Hu) mouse IgG2b sc-398134 e-Nacalai.jpg
Syndecan-3 (G-2) Ms, Rt, Hu, Hs, Ca, Bov 64-91 (Rt) mouse IgM sc-398194 e-Nacalai.jpg
TAB2 (E-5) Ms, Hu, Hs, Ca, Bov, Por 48-73 (Hu) mouse IgG2a sc-398188 e-Nacalai.jpg
Tip41 (B-3) Hu 1-180 (Hu) mouse IgG1 sc-398145 e-Nacalai.jpg
TMTC3 (G-9) Ms, Rt, Hu, Av 892-915 (Hu) mouse IgG2a sc-398137 e-Nacalai.jpg
ZFAND2B (D-10) Ms, Rt, Hu, Hs 128-151 (Hu) mouse IgG2a sc-398215 e-Nacalai.jpg
細胞膜受容体
IGF-IRβ (D-11) Ms, Rt, Hu, Hs, Ca, Bov, Por, Av 1333-1366 (Hu) mouse IgG2a sc-398250 e-Nacalai.jpg
IL-3/IL-5/GM-CSFRβ (A-3) Hu 21-46 (Hu) mouse IgG1 sc-398246 e-Nacalai.jpg
p-gp130 (D-3) Ms, Rt, Hu Ser 782 (Hu) mouse IgG2b sc-377570 e-Nacalai.jpg
PDGFR-α (C-9) Ms, Hu, Hs, Ca, Bov, Por 951-1089 (Hu) mouse IgG1 sc-398206 e-Nacalai.jpg
転写因子
BTBD1 (A-12) Hu 1-60 (Hu) mouse IgG1 sc-398235 e-Nacalai.jpg
CARP (E-3) Hu 14-39 (Hu) mouse IgG1 sc-398139 e-Nacalai.jpg
CTCF (C-9) Ms, Rt, Hu 2-23 (Hu) mouse IgG2b sc-398149 e-Nacalai.jpg
CWC22 (A-6) Hu, Ca 121-420 (Hu) mouse IgG1 sc-398178 e-Nacalai.jpg
DDX17 (H-7) Ms, Rt, Hu 60-79 (Hu) mouse IgG2a sc-398168 e-Nacalai.jpg
dHAND (A-12) Hu 1-110 (Hu) mouse IgG1 sc-398167 e-Nacalai.jpg
GIOT-1 (C-12) Hu 71-98 (Hu) mouse IgM sc-398187 e-Nacalai.jpg
HR (D-4) Hu 1-300 (Hu) mouse IgG1 sc-398176 e-Nacalai.jpg
ICSBP (F-11) Ms, Rt 248-269 (Ms) mouse IgG1 sc-398237 e-Nacalai.jpg
LRRFIP1 (C-3) Hu 770-797 (Hu) mouse IgG2a sc-398240 e-Nacalai.jpg
MBD4 (G-7) Ms, Rt, Hu, Hs, Ca, Bov 521-546 (Ms) mouse IgG1 sc-398249 e-Nacalai.jpg
Med4 (D-6) Hu 1-270 (Hu) mouse IgG2b sc-398179 e-Nacalai.jpg
Med4 (D-7) Hu 1-270 (Hu) mouse IgG1 sc-398180 e-Nacalai.jpg
NFAT5 (F-9) Hu, Hs, Ca, Bov, Por 67-300 (Hu) mouse IgG2a sc-398171 e-Nacalai.jpg
NNP-1B (C-12) Hu 459-758 (Hu) mouse IgG1 sc-398162 e-Nacalai.jpg
POLA2 (D-2) Hu 121-420 (Hu) mouse IgG1 sc-398255 e-Nacalai.jpg
POLR2G (C-2) Ms, Rt, Hu, Hs, Ca, Bov, Por 1-172 (Hu) mouse IgG1 sc-398213 e-Nacalai.jpg
Sox-2 (D-9) Ms, Rt, Hu, Hs, Ca, Bov, Por, Av 267-291 (Hu) mouse IgM sc-398254 e-Nacalai.jpg
Stat4 (C-4) Ms, Rt, Hu, Hs, Ca, Bov, Por, Av 10-31 (Ms) mouse IgG2b sc-398228 e-Nacalai.jpg
TEF-1 (B-2) Ms, Rt, Hu, Hs, Ca, Bov, Por 181-208 (Hu) mouse IgG2a sc-398227 e-Nacalai.jpg
YAP (B-8) Ms, Rt, Hu 294-323 (Hu) mouse IgG2a sc-398182 e-Nacalai.jpg
YB-1 (E-7) Hu 196-240 (Hu) mouse IgG1 sc-398146 e-Nacalai.jpg
ZBP-89 (E-6) Ms, Rt, Hu, Hs, Ca, Bov, Por 675-702 (Hu) mouse IgG1 sc-398148 e-Nacalai.jpg
ZNF276 (F-10) Ms, Rt, Hu 450-475 (Hu) mouse IgG2a sc-398207 e-Nacalai.jpg
ZNF512 (A-1) Ms, Rt, Hu, Hs, Ca, Bov, Por 41-62 (Hu) mouse IgG2b sc-398142 e-Nacalai.jpg
ZNF512 (A-8) Ms, Rt, Hu, Hs, Ca, Bov, Por 41-62 (Hu) mouse IgG2a sc-398143 e-Nacalai.jpg
ZPR1 (C-1) Ms, Rt, Hu 430-459 (Ms) mouse IgG2a sc-398241 e-Nacalai.jpg
成長因子とホルモン
IL-2 (B-7) Hu 91-112 (Hu) mouse IgG1 sc-398253 e-Nacalai.jpg
IL-3 (F-6) Ms > Rt 117-146 (Ms) mouse IgG2a sc-398177 e-Nacalai.jpg
IL-3 (G-11) Ms > Rt 137-156 (Ms) mouse IgG1 sc-398210 e-Nacalai.jpg
リンパ球シグナル伝達
C5β (E-8) Ms, Rt, Hu 562-589 (Hu) mouse IgG2a sc-398247 e-Nacalai.jpg
CD73 (D-12) Hu 275-574 (Hu) mouse IgG1 sc-398260 e-Nacalai.jpg
EBF (H-6) Ms, Rt, Hu, Hs, Ca, Bov, Por, Av 376-405 (Hu) mouse IgG1 sc-398173 e-Nacalai.jpg
Factor H (D-8) Hu 264-297 (Hu) mouse IgG1 sc-398245 e-Nacalai.jpg
LAIR-1 (F-5) Hu 182-287 (Hu) mouse IgG2a sc-398141 e-Nacalai.jpg
LAIR-1 (G-1) Hu 182-287 (Hu) mouse IgG2b sc-398140 e-Nacalai.jpg
LAMP-5 (E-8) Ms, Rt, Hu, Hs, Bov, Por 173-196 (Hu) mouse IgM sc-398190 e-Nacalai.jpg
NT5DC1 (B-3) Hu 277-364 (Hu) mouse IgG2b sc-398165 e-Nacalai.jpg
Siglec-7 (F-2) Hu 407-454 (Hu) mouse IgG1 sc-398181 e-Nacalai.jpg
Siglec-7 (H-2) Hu 407-454 (Hu) mouse IgG2b sc-398166 e-Nacalai.jpg
TdT (B-9) Hu 450-509 (Hu) mouse IgG2a sc-398238 e-Nacalai.jpg
ホメオドメインタンパク質
Dlx-5 (H-4) Ms, Rt, Hu 98-127 (Hu) mouse IgM sc-398150 e-Nacalai.jpg
Six1/2/4 (E-11) Ms, Rt, Hu, Hs, Ca, Bov, Por, Av 18-43 (Hu) mouse IgG1 sc-398193 e-Nacalai.jpg
細胞接着タンパク質
α T-catenin (B-6) Hu 61-125 (Hu) mouse IgG1 sc-398138 e-Nacalai.jpg
γ-catenin (D-12) Ms, Rt, Hu, Ca 716-743 (Hu) mouse IgG2a sc-398183 e-Nacalai.jpg
Integrin β5 (F-5) Ms, Rt, Hu 72-99 (Hu) mouse IgG2a sc-398214 e-Nacalai.jpg
PCDH1 (B-11) Hu 237-329 (Hu) mouse IgG1 sc-398263 e-Nacalai.jpg
チャネルタンパク質
CNG-β3 (C-4) Hu 78-97 (Hu) mouse IgG2b sc-398211 e-Nacalai.jpg
ステロイド受容体
Rev-erbβ (D-8) Ms, Hu 195-267 (Ms) mouse IgG1 sc-398252 e-Nacalai.jpg
SF-1 (G-12) Hu 201-260 (Hu) mouse IgG1 sc-398202 e-Nacalai.jpg
細胞周期タンパク質
BRD1 (F-12) Ms, Rt, Hu 77-98 (Hu) mouse IgG1 sc-398226 e-Nacalai.jpg
Dcun1D1/2 (A-11) Hu, Hs, Ca, Bov, Por 71-233 (Hu) mouse IgG2a sc-398218 e-Nacalai.jpg
FIGNL1 (A-4) Ms, Hu 378-423 (Hu) mouse IgG2a sc-398264 e-Nacalai.jpg
p-p21 (D-6) Ms, Rt, Hu, Ca, Por, Av Thr 145 (Hu) mouse IgG3 sc-377569 e-Nacalai.jpg
SA-2 (G-12) Ms, Rt, Hu 1174-1203 (Hu) mouse IgG3 sc-398229 e-Nacalai.jpg
その他
ATPBD4 (G-6) Ms, Rt, Hu, Ca, Bov 189-216 (Hu) mouse IgG1 sc-398185 e-Nacalai.jpg
C20orf177 (E-11) Hu 34-51 (Hu) mouse IgM sc-398170 e-Nacalai.jpg
DEPTOR (A-3) Ms, Rt, Hu 18-37 (Hu) mouse IgG1 sc-398169 e-Nacalai.jpg
MBLAC2 (E-7) Ms, Rt, Hu, Bov, Por 82-107 (Hu) mouse IgG2a sc-398153 e-Nacalai.jpg
Extracellular solute-binding protein (B-5) S. equi 1-288 (Streptococcus equi subsp. equi 4047) mouse IgG2a sc-398158 e-Nacalai.jpg
Metal ABC transporter substrate-binding lipoprotein (G-5) S. equi 1-310 (Streptococcus equi subsp. equi 4047) mouse IgG2a sc-398159 e-Nacalai.jpg
Signal peptidase I (A-12) Streptococcus equi subsp. equi 4047 1-185 (Streptococcus equi subsp. equi 4047) mouse IgG1 sc-398136 e-Nacalai.jpg
UDPase (D-4) Streptococcus equi subsp. zooepidemicus/Streptococcus equi subsp. equi 4047 1-300 (S) mouse IgG1 sc-398133 e-Nacalai.jpg

※記載の内容は、'14年5月現在の情報に基づいております。

LabFab News Vol.12 June発行

$
0
0
掲載内容

製薬企業ライセンス化合物 新製品

Tocris

Tocris 社では、さまざまな製薬企業が開発し特許を保持している化合物を、特許権者の許諾のもと、製造・販売しています。Tocris 社では、これらの開発化合物を、多数取り扱っています。今回はその中から新製品を紹介します。

CpG ODN新製品
TLR9 リガンド

InvivoGen

CpG モチーフ(CpG ODN)を含む合成オリゴデオキシヌクレオチドはTLR9 依存的な免疫応答を誘導するために広く利用されています。InvivoGen 社より新しいCpG ODN が発売されましたので紹介します。本製品群はアゴニストまたはアンタゴニスト活性を有することと、夾雑物であるエンドトキシンおよびペプチドグリカンがフリーであることを、レポーター細胞により実際に試験しています。

長期間高い生存率を維持
GS21™ 神経細胞培養用サプリメント

GlobalStem

GlobalStem 社のGS21™神経細胞培養用サプリメントは、血清フリーの培地サプリメントでNS21 をベースとしています。本製品は、特にラットやマウスの初代神経細胞の成熟時や長期間の維持培養に適しています。

細胞から排出されにくい蛍光カルシウムインジケーター
Cal-520™

AAT Bioquest

Fluo-8® でご好評いただいているAAT Bioquest 社のカルシウムインジケーターCal-520™を紹介します。本製品は他の指示薬よりも細胞残存率が高いため、プロベネシド等の陰イオントランスポーター阻害剤を加えなくても使用可能です。細胞膜透過性のアセトキシメチル基(AM)が付加されている製品もあります。

蛍光染色用の封入剤
Fluoro-KEEPER Antifade Reagent, Non-Hardening Type

ナカライテスク

本製品は独自の退色防止剤を含有した非固化タイプの封入剤であり、蛍光顕微鏡観察時に起こる蛍光の急激な退色を防止します。また、カバーガラスの端をマニキュア等でシーリングした標本は数週間の保存も可能です。

リポフスチン自家蛍光抑制試薬
TrueBlack™

Biotium

リポフスチンは加齢に伴い細胞に蓄積する物質で、自家蛍光を強く発するため組織の蛍光観察を難しくしています。そのリポフスチンの影響を抑えるためにスダンブラックB が使用されていますが、バックグラウンドが高くなるという問題がありました。この度Biotium 社が低バックグラウンドでリポフスチン自家蛍光を抑制する試薬を発売しましたので、紹介します。

K63 ポリユビキチン化タンパク質を特異的に検出・精製
K63 TUBE1

LifeSensors

LifeSensors 社はユビキチン研究用試薬について一般的な製品から特長的なものまで取り揃えています。今回はペプチドを基に作製されたK63 ポリユビキチン鎖を特異的に精製する試薬を紹介します。Far- ウェスタン(Biotin K63-TUBE1)や、精製(DYKDDDDK K63-TUBE1)、in situ 検出(Fluorophore K63-TUBE1)等にご利用いただけます。

がんバイオマーカー抗体

Atlas Antibodies

Atlas Antibodies 社の抗体は、正常・がん組織や各種細胞株で検証した免疫染色のデータが豊富でヒト細胞/組織の免疫染色におすすめです。今回は、がんのバイオマーカーであるRBM3、SATB2、PODXL に対する抗体から一部の製品を紹介します。

さまざまな研究対象の抗体がさらに充実
モノクローナル抗体 新製品

Santa Cruz

Santa Cruz 社では、合成と分解、シグナル中間体、転写因子などさまざまな研究対象の抗体に、新しくラインアップを追加しました。今回はその中から、一部の製品を紹介します。

HPLC 装置で使用可能な超高速LC カラム
COSMOCORE™ 2.6C18

ナカライテスク

COSMOCORE™ 2.6C18 は、Core-Shell 担体を充填剤に採用した超高速LC カラムです。Core-Shell 担体の特性により通常HPLC 装置の圧力範囲内で分析時間を大幅に短縮することが可能となります。

Web siteからのご請求、PDF版ダウンロードはこちら

 

 

lab_57_200.jpg

 

崩壊試験用・溶出試験用関連製品キャンペーン

$
0
0

【期  間】

2014年6月2日(月)~7月31日(木)

 

【内  容】

希望納入価格の最大40%OFF

 

 

 

 

Santa Cruz社 モノクローナル抗体 2014年2月新製品

$
0
0

Santa Cruz社 モノクローナル抗体 2014年2月新製品

Santa Cruz社では、合成と分解、シグナル中間体、転写因子など様々な研究対象のモノクローナル抗体を新発売しました。

 

 

新製品一覧

容量:200μg/ml  価格:51,000円

略号:Av=Avian(Bird), Bov=Bovine(Cow), Ca=Canine, Hs=Horse(Equine), Hu=Human, Ms=Mouse, Por=Porcine(Pig, Swine), Rt=Rat, WB=Western Blotting, IP=Immunoprecipitation, IF=Immunofluorescence, IHC-P=Immunohistochemistry Paraffin Embedded Section

製品名交差性抗原アイソタイプ用途メーカー製品番号オンライン
カタログへ
構造タンパク質
α-lactalbumin (H-1) Hu 1-142 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-393900 e-Nacalai.jpg
Grancalcin (C-10) Hu 189-214 (Hu) mouse IgG3 WB, IP, IF, ELISA sc-393984 e-Nacalai.jpg
Myotilin (B-3) Hu 331-416 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393958 e-Nacalai.jpg
Myotilin (E-10) Ms, Rt, Hu, Ca 321-420 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393957 e-Nacalai.jpg
Odf2 (G-2) Hu, Rt, Ca 86-385 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393881 e-Nacalai.jpg
S-100 β chain (C-3) Ms, Rt, Hu, Hs 31-52 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393919 e-Nacalai.jpg
TCP-1 ε (G-3) Ms, Rt, Hu 130-161 (Hu) mouse IgG3 WB, IP, IF, ELISA sc-393913 e-Nacalai.jpg
合成と分解
17β-HSD7 (F-4) Hu 121-195 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393936 e-Nacalai.jpg
20S Proteasome β5 (A-10) Hu, Bov 217-263 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393931 e-Nacalai.jpg
ABHD5 (C-8) Hu 10-29 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-393949 e-Nacalai.jpg
ADAM28 (A-5) Hu 366-420 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393877 e-Nacalai.jpg
ALDH6A1 (G-10) Ms, Rt, Hu, Ca, Por 475-498 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393914 e-Nacalai.jpg
CHDH (C-5) Hu 295-594 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393885 e-Nacalai.jpg
COQ6 (H-1) Ms, Rt, Hu, Hs, Ca, Bov, Por 130-155 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393932 e-Nacalai.jpg
CYP1A1 (A-9) Ms, Rt, Hu 479-506 (Ms) mouse IgG1 WB, IP, IF, ELISA sc-393979 e-Nacalai.jpg
GS2 (D-1) Hu 85-104 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393944 e-Nacalai.jpg
GS2 (E-8) Hu 90-121 (Hu) mouse IgG3 WB, IP, IF, ELISA sc-393988 e-Nacalai.jpg
NAT-1/2 (A-1) Ms, Rt, Hu 189-210 (Ms) mouse IgM WB, IP, IF, ELISA sc-393937 e-Nacalai.jpg
PCCB (E-12) Hu 240-539 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393929 e-Nacalai.jpg
TRP1 (F-7) Ms, Rt 526-536 (Ms) mouse IgG2b WB, IP, IF, ELISA sc-393942 e-Nacalai.jpg
USP14 (A-1) Hu, Ca 195-494 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393872 e-Nacalai.jpg
USP43 (H-10) Ms, Rt, Hu 1094-1115 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-393895 e-Nacalai.jpg
神経生物学
plexin-A2 (A-2) Ms, Rt, Hu, Hs, Ca, Bov 1159-1196 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393939 e-Nacalai.jpg
Shank 1/2/3 (G-12) Ms, Rt, Hu, Ca, Bov, Por 2124-2153 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393963 e-Nacalai.jpg
Synaptogyrin-4 (F-11) Ms, Rt > Hu 210-233 (Ms) mouse IgG1 WB, IP, IF, ELISA sc-393912 e-Nacalai.jpg
輸送関連タンパク質
ACSVL1 (D-7) Hu 41-167 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393906 e-Nacalai.jpg
COPG (A-10) Ms, Rt, Hu 849-874 (Ms) mouse IgG1 WB, IP, IF, ELISA sc-393977 e-Nacalai.jpg
Endophilin B2 (E-2) Ms, Rt, Hu, Hs, Ca, Bov, Por 349-374 (Hu) mouse IgG3 WB, IP, IF, ELISA sc-393989 e-Nacalai.jpg
GP73 (E-7) Ms 365-392 (Ms) mouse IgG2a WB, IP, IF, ELISA sc-393935 e-Nacalai.jpg
p-Dynamin I (F-11) Ms, Rt, Hu, Ca, Bov, Por, Av Ser 795 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-377568 e-Nacalai.jpg
SCO1 (D-1) Ms, Rt, Hu 183-210 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-398001 e-Nacalai.jpg
SNX4 (H-8) Hu, Hs 151-450 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393954 e-Nacalai.jpg
キナーゼとホスファターゼ
Blk (F-1) Hu 27-52 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393996 e-Nacalai.jpg
Blk (G-8) Hu 27-52 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-393960 e-Nacalai.jpg
cGKIα (F-5) Hu, Hs, Ca, Bov, Por 62-89 (Hu) mouse IgM WB, IP, IF, ELISA sc-393987 e-Nacalai.jpg
CLK2 (F-4) Ms, Rt, Hu 70-97 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393909 e-Nacalai.jpg
p70 S6 kinase α (B-5) Ms, Rt, Hu, Hs, Ca, Bov, Por, Av 261-430 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393967 e-Nacalai.jpg
phospholamban (F-7) Ms, Rt, Hu 7-32 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393990 e-Nacalai.jpg
PTP IA-2β (B-4) Hu 61-360 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393922 e-Nacalai.jpg
VHY (F-11) Ms, Rt, Hu 10-37 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393888 e-Nacalai.jpg
腫瘍抑制因子 / アポトーシス
caspase-10 p10 (E-11) Hu 458-479 (Hu) mouse IgM WB, IP, IF, ELISA sc-393983 e-Nacalai.jpg
FAF1 (E-4) Hu 182-480 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-393965 e-Nacalai.jpg
ICAD (H-10) Hu 308-331 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-393886 e-Nacalai.jpg
シグナル中間体
Abi-2 (B-3) Ms, Rt, Hu, Hs, Ca, Bov, Por, Av 220-249 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393982 e-Nacalai.jpg
Ajuba (B-3) Ms, Rt, Hu 67-94 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-398008 e-Nacalai.jpg
BPGM (B-11) Ms, Rt, Hu, Hs, Ca, Bov 90-119 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393964 e-Nacalai.jpg
CLN2 (G-3) Ms, Rt, Hu 504-531 (Rt) mouse IgG2a WB, IP, IF, ELISA sc-393961 e-Nacalai.jpg
CPSF7 (A-9) Ms, Rt, Hu, Hs, Ca, Bov, Por 185-237 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393880 e-Nacalai.jpg
CRELD2 (C-6) Ms 171-290 (Ms) mouse IgG2b WB, IP, IF, ELISA sc-393980 e-Nacalai.jpg
FBXO2 (A-12) Ms, Rt, Hu 140-171 (Hu) mouse IgM WB, IP, IF, ELISA sc-393873 e-Nacalai.jpg
FNDC3B (B-1) Ms, Rt, Hu 6-21 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393997 e-Nacalai.jpg
FNDC3B (B-6) Ms, Hu, Hs, Ca, Bov 1-42 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-393875 e-Nacalai.jpg
fumarate hydratase (H-6) Ms, Hu 426-510 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393992 e-Nacalai.jpg
Headpin (B-5) Ms, Rt 260-287 (Rt) mouse IgG2a WB, IP, IF, ELISA sc-393882 e-Nacalai.jpg
Herc1 (E-12) Hu, Hs, Por 591-890 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393950 e-Nacalai.jpg
HPRT (A-3) Ms, Rt, Hu, Hs, Bov, Por 16-41 (Hu) mouse IgM WB, IP, IF, ELISA sc-393915 e-Nacalai.jpg
HPRT (B-11) Ms, Rt, Hu, Hs, Bov, Por 16-39 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393901 e-Nacalai.jpg
IDE (F-9) Ms, Rt, Hu 122-145 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393887 e-Nacalai.jpg
KAO (F-9) Hu 351-429 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-398006 e-Nacalai.jpg
MIA3 (C-5) Hu 1391-1546 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393916 e-Nacalai.jpg
Peroxin 26 (F-7) Hu 3-180 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393884 e-Nacalai.jpg
PNMTase (C-7) Hu 164-212 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393995 e-Nacalai.jpg
SAP (C-11) Hu 175-202 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393948 e-Nacalai.jpg
SDF-4 (E-12) Ms, Rt, Hu 196-219 (Hu) mouse IgM WB, IP, IF, ELISA sc-393930 e-Nacalai.jpg
TRIM23 (C-1) Hu 1-300 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393923 e-Nacalai.jpg
ZFAND2B (D-2) Ms, Rt, Hu, Hs 128-149 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-398000 e-Nacalai.jpg
細胞膜受容体
8D6 (F-12) Hu 152-282 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393892 e-Nacalai.jpg
ASGPR2 (C-4) Rt 81-155 (Rt) mouse IgG2b WB, IP, IF, ELISA sc-393883 e-Nacalai.jpg
c-Kit (H-10) Hu > Ms 953-976 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393910 e-Nacalai.jpg
EphA7 (E-7) Ms, Rt, Hu 39-62 (Ms) mouse IgG1 WB, IP, IF, ELISA sc-393973 e-Nacalai.jpg
EphA7 (F-10) Ms, Rt, Hu 39-62 (Ms) mouse IgG2a WB, IP, IF, ELISA sc-393974 e-Nacalai.jpg
Flg (F-3) Ms, Rt, Hu, Hs, Ca, Bov, Por 111-122 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-393911 e-Nacalai.jpg
IL-1RI (H-8) Ms, Rt 539-563 (Ms) mouse IgG1 WB, IP, IF, ELISA sc-393998 e-Nacalai.jpg
Notch 4 (A-12) Ms, Rt, Hu 1933-1964 (Ms) mouse IgG2a WB, IP, IF, ELISA sc-393893 e-Nacalai.jpg
転写因子
BTBD2 (H-2) Hu 1-43 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393927 e-Nacalai.jpg
CstF-50 (G-3) Ms, Rt, Hu, Hs, Ca, Bov, Por, Av 372-397 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393962 e-Nacalai.jpg
EF-Tu (A-5) Hu 171-455 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393924 e-Nacalai.jpg
FBP1 (A-4) Hu, Hs, Ca, Bov 65-106 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393928 e-Nacalai.jpg
HDAC9 (B-1) Ms, Rt, Hu 12-39 (Hu) mouse IgM WB, IP, IF, ELISA sc-398003 e-Nacalai.jpg
HNF-1 (F-7) Hu, Ca, Por 80-284 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393925 e-Nacalai.jpg
hnRNP UL1 (C-2) Hu, Hs, Ca, Por 565-604 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393975 e-Nacalai.jpg
HSPC117 (C-3) Hu, Hs, Ca, Bov, Por 206-505 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393966 e-Nacalai.jpg
ICSBP (H-12) Ms, Rt, Hu 399-425 (Ms) mouse IgG3 WB, IP, IF, ELISA sc-393955 e-Nacalai.jpg
KCTD13 (B-12) Hu 33-329 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393994 e-Nacalai.jpg
KCTD14 (A-12) Ms, Rt, Hu 118-139 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393889 e-Nacalai.jpg
KCTD14 (A-6) Ms, Rt, Hu 132-157 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-393876 e-Nacalai.jpg
KCTD14 (H-8) Ms, Rt, Hu 118-145 (Hu) mouse IgG3 WB, IP, IF, ELISA sc-393917 e-Nacalai.jpg
myogenin (G-3) Ms, Rt, Hu, Hs, Por 174-205 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-398002 e-Nacalai.jpg
NELF-D (C-10) Hu 1-300 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393972 e-Nacalai.jpg
NIPP1 (A-11) Hu, Rt, Hs, Ca, Bov, Por 221-351 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393991 e-Nacalai.jpg
OAZ (E-6) Hu, Hs, Ca, Bov, Por, Av 35-58 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393904 e-Nacalai.jpg
ORC4 (D-8) Ms, Rt, Hu 375-398 (Hu) mouse IgM WB, IP, IF, ELISA sc-393985 e-Nacalai.jpg
POLR2G (G-9) Ms, Rt, Hu, Hs, Ca, Bov, Por 1-172 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393890 e-Nacalai.jpg
Pontin 52 (A-11) Ms, Rt, Hu, Hs, Ca, Bov, Av 191-290 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393905 e-Nacalai.jpg
RPA 14 kDa subunit (A-2) Ms 96-121 (Ms) mouse IgG2a WB, IP, IF, ELISA sc-393891 e-Nacalai.jpg
SPT6 (C-6) Ms, Rt, Hu, Hs, Ca, Bov 1001-1227 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393938 e-Nacalai.jpg
SPT6 (E-4) Ms, Rt, Hu, Hs, Ca, Bov 1001-1227 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393920 e-Nacalai.jpg
TAF II p250 (A-10) Ms, Rt, Hu, Hs, Ca, Bov, Av 1276-1315 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-393981 e-Nacalai.jpg
TEF-1 (E-5) Ms, Rt, Hu, Hs, Ca, Bov, Por 174-209 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393976 e-Nacalai.jpg
XPA (B-7) Hu > Ms, Rt 15-39 (Hu) mouse IgM WB, IP, IF, ELISA sc-398005 e-Nacalai.jpg
成長因子とホルモン
CCL23 (H-2) Hu 26-49 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393897 e-Nacalai.jpg
Chr-A (C-12) Ms, Rt, Hu, Hs 442-457 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393941 e-Nacalai.jpg
IL-2 (G-6) Hu 89-118 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-393947 e-Nacalai.jpg
MIP-1α (E-2) Hu 23-54 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393899 e-Nacalai.jpg
Neurophysin I (D-11) Ms, Rt 101-127 (Ms) mouse IgM WB, IP, IF, ELISA sc-393907 e-Nacalai.jpg
VEGF-C (F-5) Ms, Rt, Hu 29-52 (Hu) mouse IgM WB, IP, IF, ELISA sc-398004 e-Nacalai.jpg
リンパ球シグナル伝達
CD20 (D-10) Ms, Rt, Hu 265-290 (Ms) mouse IgM WB, IP, IF, ELISA sc-393894 e-Nacalai.jpg
CD68 (C-9) Hu 27-60 (Hu) mouse IgG3 WB, IP, IF, ELISA sc-393951 e-Nacalai.jpg
GDP / GTP結合タンパク質
AKAP 13 (A-3) Hu 1-284 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393953 e-Nacalai.jpg
15 (F-3) Hu 1-45 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393878 e-Nacalai.jpg
o (E-1) Ms, Rt, Hu, Hs, Bov 40-291 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393874 e-Nacalai.jpg
3 (G-5) Ms, Rt, Hu 25-52 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393908 e-Nacalai.jpg
3 (C-6) broad, Hs, Ca, Bov, Por 2-27 (Bov) mouse IgG2b WB, IP, IF, ELISA sc-393940 e-Nacalai.jpg
GTPBP9 (G-6) Ms, Rt, Hu, Bov 60-83 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393946 e-Nacalai.jpg
ホメオドメインタンパク質
Dlx-2 (B-5) Ms, Hu 211-250 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393879 e-Nacalai.jpg
HoxB6 (D-12) Ms, Rt, Hu 82-111 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-393926 e-Nacalai.jpg
HoxB6 (F-1) Ms, Rt, Hu 81-112 (Hu) mouse IgM WB, IP, IF, ELISA sc-393978 e-Nacalai.jpg
Msx-2 (B-2) Ms, Rt, Hu 11-37 (Hu) mouse IgG3 WB, IP, IF, ELISA sc-393986 e-Nacalai.jpg
Pit-1 (D-7) Ms, Rt, Hu 5-32 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393943 e-Nacalai.jpg
細胞接着タンパク質
fibrillin-2 (H-10) Ms, Hu 397-436 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393968 e-Nacalai.jpg
Mucin 5B (A-3) Hu 1201-1500 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393952 e-Nacalai.jpg
N-cadherin (F-5) Ms, Rt, Hu 800-825 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393934 e-Nacalai.jpg
N-cadherin (H-2) Ms, Rt, Hu 800-825 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393933 e-Nacalai.jpg
Sgo1 (F-8) Hu 1-116 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393993 e-Nacalai.jpg
チャネルタンパク質
GABAA Rα5 (A-5) Hu 356-415 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393921 e-Nacalai.jpg
ステロイド受容体
ERRγ (D-1) Hu, Hs, Ca, Bov, Por 81-118 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393969 e-Nacalai.jpg
NOR-1 (F-10) Ms, Rt, Hu, Por 227-262 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393903 e-Nacalai.jpg
NOR-1 (H-7) Ms, Rt, Hu, Por 222-259 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393902 e-Nacalai.jpg
TRβ1 (A-7) Ms, Rt, Hu 2-27 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-398007 e-Nacalai.jpg
細胞周期タンパク質
GIGYF2 (A-12) Ms, Rt, Hu 1274-1297 (Hu) mouse IgG2b WB, IP, IF, ELISA sc-393918 e-Nacalai.jpg
その他
C19orf47 (H-5) Ms, Rt, Hu 199-234 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393896 e-Nacalai.jpg
FAM117A (G-5) Ms, Rt, Hamster 417-446 (Ms) mouse IgG2a WB, IP, IF, ELISA sc-393898 e-Nacalai.jpg
FAM167A (G-3) Ms, Rt, Hu 42-67 (Hu) mouse IgG2a WB, IP, IF, ELISA sc-393999 e-Nacalai.jpg
SCYL3 (G-9) Ms, Rt, Hu, Hs, Ca, Bov, Por 70-96 (Hu) mouse IgG1 WB, IP, IF, ELISA sc-393945 e-Nacalai.jpg
8-OHdG (E-8)     mouse IgM IF, IHC-P, ELISA sc-393871 e-Nacalai.jpg
8-OHdG (F-12)     mouse IgM IF, IHC-P, ELISA sc-393870 e-Nacalai.jpg
Amino acid-binding ABC transporter (E-5) S. equi 1-278 (Streptococcus equi subsp. equi 4047) mouse IgG2a WB, IP, IF, ELISA sc-393959 e-Nacalai.jpg
lipoprotein (A-9) S. equi 1-216 (Streptococcus equi subsp. equi 4047) mouse IgG2b WB, IP, IF, ELISA sc-393970 e-Nacalai.jpg
lipoprotein (F-8) S. equi 1-216 (Streptococcus equi subsp. equi 4047) mouse IgG1 WB, IP, IF, ELISA sc-393971 e-Nacalai.jpg
chondroitin sulfate (A-7) N/A N/A mouse IgM WB, IP, IF, ELISA sc-393956 e-Nacalai.jpg

※記載の内容は、'14年4月現在の情報に基づいております。


Strem社 RAFT剤

$
0
0

分子量制御が容易な重合剤
RAFT剤

stremlogo_cyan_hi_web.jpg

 

 

 

RAFT(Reversible Addition Fragmentation chain Transfer)重合は、リビング重合の一種であり1998年CSIRO(Commonwealth Scientific and Industrial Research Organisation)にて発見された重合反応です。この重合反応は、狭い分子量分布で重合可能なことから注目されています。Strem社では、さまざまなモノマーに対応するRAFT剤を用意しています。 

 

特長

  • 狭い分子量分布で重合可能
  • さまざまなモノマーに対応するRAFT剤をご用意
  • 複合構造(ブロック、グラフト、星型など)を有する共重合体の合成も可能

 

 

RAFT重合のメカニズム

RAFT重合では、一般的なラジカル重合の素反応(開始・成長・停止)に加えて下記のような速いRAFT平衡が起こります。重合生成物中に、チオカルボニルチオ基が生成されるために、副反応である不可逆的連鎖移動や停止反応が起こりにくく、狭い分子量範囲で重合可能です。このことにより、等量数など反応条件を調整することにより分子量制御した重合が可能となります。

RAFT.jpg

 

 

モノマー適合表 

一般的なモノマーに対するRAFT剤との適合表です。スチレンやメタクリラートは各種RAFT剤に適しています。一方、ビニルエステルやビニルアミドは、適合するRAFT剤が限定されます。Strem社では各RAFT剤500mgから構成されるキット(#96-4700)も提供しています。

RAFT剤メーカー製品番号16-042316-042516-043016-042216-061016-041516-046016-0617
Monomerstyrenes
acrylates
acrylamides
methacrylates
methacrylamides
vinyl esteres
vinyl amides
◎:精密な分子量制御(分子量分散RD<1.2以下)
〇:一定の分子量制御(不要な停止反応は防ぎ、分子量分散RD<1.3以下で制御可能。)
△:制限した分子量制御(分子量分散RD<1.5以下での制御。もしくは不要な停止反応が起こる。)
―:分子量制御できない。もしくは不要な停止反応が容易に発生する。

 

価格表
製品名毒劇物メーカー
製品番号
容量価格オンライン
カタログへ
RAFT Agent Kit for controlling polymerizations at the molecular level 96-4700 1 kit 118,500 e-Nacalai.jpg
2-Cyanomethyl-N-methyl-N-phenyldithiocarbamate, min. 97% 16-0423 500 mg 14,400 e-Nacalai.jpg
S-Cyanomethyl-S-dodecyltrithiocarbonate, min. 97% 16-0425 500 mg 16,500 e-Nacalai.jpg
2-Cyanoprop-2-yl-dithiobenzoate, min. 97% 16-0430 500 mg 14,400 e-Nacalai.jpg
4-Cyano-4-(thiobenzoylthio)pentanoic Acid, min. 97% 16-0422 500 mg 15,000 e-Nacalai.jpg
S-(2-Cyanoprop-2-yl)-S-dodecyltrithiocarbonate, min. 97% 16-0610 500 mg 14,400 e-Nacalai.jpg
4-Cyano-4-(dodecylsulfanylthiocarbonyl)sulfanylpentanoic Acid, min. 97% 16-0415 500 mg 16,500 e-Nacalai.jpg
2-Methyl-2-[(dodecylsulfanylthiocarbonyl)sulfanyl]propanoic Acid, min. 97%   16-0460 500 mg 14,400 e-Nacalai.jpg
S,S-Dibenzyltrithiocarbonate, min. 97%   16-0617 500 mg 14,400 e-Nacalai.jpg

※記載の内容は、'14年5月現在の情報に基づいております。

エタノール沈殿を促進 Gene-Packman Coprecipitant

$
0
0

エタノール沈殿を促進
Gene-Packman Coprecipitant

ジーンパックマン共沈剤は、DNAやRNAなどの核酸をエタノール沈殿/イソプロパノール沈殿させる際に使用するアクリルアミド系共沈剤です。希薄な核酸溶液に本製品を添加することで、冷却不要で直ちに遠心操作を行えるだけでなく、微量な核酸サンプルの回収率を上げることができます。

 

 

特長
  • 微量核酸の回収率が上昇
  • 沈殿が容易に目視可能で実験操作が安心
  • 冷却不要で迅速なエタノール沈殿が可能
  • エンドトキシン、DNase、RNase試験済み

 

 

性能評価1

大腸菌からプラスミドDNAを抽出し、その抽出したプラスミドDNAに対して、本製品またはA社製品を用いたエタノール沈殿を行った。また、共沈剤を用いない一般的なエタノール沈殿を行い、これらの精製プラスミドDNAをアガロースゲル電気泳動によって比較した。

 

■分析手順

 tejun.jpg

 

■試薬・キット

・本製品  ・A社製品  ・エタノール(#14713)
・NucleoSpin® Plamid QuickPure(MACHEREY-NAGEL #740615.250)

 

■結果(アガロース電気泳動)

 kekka.jpg

①1kbp DNA Ladder One(#08232)  ②A社製品  ③本製品
④エタノール沈殿(共沈剤なし)  ⑤粗精製プラスミドDNA

 

上図より、本製品またはA社製品を用いることで、従来のエタノール沈殿に比べ高純度、高収率でプラスミドDNAを精製することができた。また、本製品による精製DNAとA社製品による精製DNAで、アガロース電気泳動の結果に差は見られなかった。

 

データご提供:

(公財)京都高度技術研究所(ASTEM)

産学連携事業部連携支援グループ(京都バイオ計測センター) 奥村 健太 様

(地独)京都市産業技術研究所 バイオ系チーム 泊 直宏 研究員 

 

 

性能評価2

■微量核酸の回収

λ/HindⅢ(10ng/500μl)を0.1 mol/l酢酸ナトリウム存在下にて1 mlのエタノールを加え、各条件で沈殿させたDNAのアガロース電気泳動を行った。

hyouka2.jpg

①1kbp DNA Ladder One(#08232)
②λ/HindⅢ(Control)
③λ/HindⅢ+本製品 3μl(直ちに遠心)
④λ/HindⅢ-20℃、60分間
⑤λ/HindⅢ-80℃、60分間
⑥λ/HindⅢ+A社製品 3μl(直ちに遠心)
⑦λ/HindⅢ+B社製品 5μl(直ちに遠心)*
⑧λ/HindⅢ+Glycogen Soln. (#17110) 3μl(直ちに遠心)
*B社製品は、添付文書に従って0.3 mol/l酢酸ナトリウム存在下でエタノール沈殿を実施した。 

 

以上の結果より、他社製品と同様に低温保存をしなくても微量DNAが十分に回収できることが示されました。

 

 

性能評価3

 ■PCRに及ぼす影響

本製品がPCRへ与える影響を調べるために、あえてPCR反応液へ加え、1,000bpのDNA領域を各社ポリメラーゼにより増幅した。反応は25μl(15ng Template DNA、0.2μM each Primer、0.2mM dNTPs、ポリメラーゼおよび緩衝液は各添付文書に従った)で94℃-0.5分間、55℃-0.5分間、72℃-1分間を25サイクル行った。

hyouka3.jpg

本製品 ①0μl  ②0.2μl  ③0.5μl  ④1μl  ⑤3μl  ⑥5μl

 

以上の結果より、本製品は、PCRに影響を及ぼさないことが示されました。

 

 

 性能評価4

 ■260nmおよび280nmにおける吸光度

本製品およびA社製品について各原液、50倍希釈溶液、100倍希釈溶液の吸光度を測定しました。実験には0.2mlの原液または希釈液を供し、石英製ミクロセル(光路長10mm-光路幅1mm)を用いて25℃における吸光度を測定しました。また試料の希釈には超純水を採用しました。

 

A260
 原液50倍希釈100倍希釈
本製品 0.342 0.012 0.007
A社製品 0.674 0.015 0.007
A280
 原液50倍希釈100倍希釈
本製品 0.283 0.010 0.005
A社製品 0.568 0.011 0.005

 

価格表
製品名規格貯法製品番号容量価格オンライン
カタログへ
Gene-Packman Coprecipitant SP 冷蔵 12680-30 1 kit 14,000 e-Nacalai.jpg
3M酢酸ナトリウム(pH5.2)添付。
本製品は100μlの試料に対して、約200回使用できます。

※記載の内容は、'14年5月現在の情報に基づいております。
※研究者の皆様のご所属等は、データご提供時の情報に基づいております。

 

Tocris社 2014年5月新製品

$
0
0

tocris-logo-web.jpg 

 

 

 

この製品に関するご意見・ご照会・お問合せはこちら

 

 

New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.

 

 

Cat.No. Product Name Activity
5175 AEBSF Broad spectrum, irreversible inhibitor of serine proteases
5110 GSK 1562590 hydrochloride High affinity and selective urotensin II (UT) receptor antagonist
5051 BIO 5192 Highly potent and selective inhibitor of integrin α4β1 
5021 TC-G 1000 Potent and selective α2D agonist
5169 Noradrenaline bitartrate Endogenous adrenergic hormone and neurotransmitter
5180 Ferrostatin 1 Selective inhibitor of erastin induced ferroptosis
5151 Prosaptide TX14(A) Potent GPR37 and GPR37L1 agonist
5113 AbK Photo-crosslinking probe
5036 ML 786 dihydrochloride Potent Raf kinase inhibitor; orally bioavailable
4886 RU-SKI 43 hydrochloride Hedgehog acyltransferase (Hhat) inhibitor; cell permeable
4875 Senexin A Cyclin-dependent kinase 8 (cdk8) inhibitor
2305 Tautomycetin Selective PP1 inhibitor
5172 FLI 06 Inhibitor of Notch signaling
5148 Wnt-C59 Highly potent Porcn inhibitor
5128 C 21 Selective PRMT1 arginine methyltransferase inhibitor
4964 R 1485 dihydrochloride Selective and high affinity 5-HT6 antagonist
1286 LY 231617 Antioxidant; neuroprotective in vitro and in vivo
5099 TC-E 5003 Selective PRMT1 arginine methyltransferase inhibitor
5050 CASIN Cdc42 GTPase inhibitor
4978 Pyrintegrin Enhances survival of human ESCs following enzymatic dissociation
4934 MA 2029 Potent and selective, competitive motilin receptor antagonist; orally active
4898 TC-E 5006 γ-secretase modulator; reduces Aβ42 levels

 

 

 

この製品に関するご意見・ご照会・お問合せはこちら

Agarose Bead Technologies社 1級アミンを固定化するアガロースビーズ Glyoxal Resins

$
0
0

アガロースビーズに好みのリガンドを結合可能

ABTlogo.gif

 

 

 

 

この製品に関するご意見・ご照会・お問合せはこちら

 

 

GLYOXAL RESINS

 

Immobilization technique allows affinity ligands’ binding giving high stability and making easy to re-use the conjugated ligand. Glyoxal beads allow a covalent binding of agarose to lysine amino groups.

ABT offers a wide range of products activated with different degree of aldehydes groups and using two different backbone (4% & 6% beads) and different particle sizes. Giving adequate options to work in batch or column purifications (Glyoxal Agarose Beads for Low Pressure applications) and large scale process (Glyoxal Rapid Run™ for High Pressure applications).

 

ABT Glyoxal resins allow a covalent binding of agarose to amino groups of ligands (antibodies, antigens, enzymes, proteins or other biomolecules). The aldehyde groups (resin) react with exposed primary amines (biomolecules). The result of the biomolecule immobilization is a stable and reusable resin for affinity purification in batch, spin column or gravity procedures.

 

 

COUPLING LIGAND

Ligand: antibody, antigen, enzyme, affinity proteins (e.g. Protein A or Protein G) or biomolecule.

 

 

FEATURE

  • Binding through Lys zones: reproducible process
  • Very stable ligand binding (covalent )
  • High ligand binding capacity
  • High specificity (no cations present)
  • Quick ligand conjugation
  • No affinity ligand loss (reusable)
  • Ready to use
  • Long shelf- life (expiration 5 years)

 

 

Low Pressure: GLYOXAL Agarose Beads

Bead (Geometry, size) Spherical, Standard: ~50 - 150µm
Cross-Linked Yes
Matrix Active Groups Agarose with some diols oxidized to aldehydes
Product Name VERY HIGH Density GLYOXAL 4BCL VERY HIGH Density GLYOXAL 6BCL HIGH Density GLYOXAL 4BCL HIGH Density GLYOXAL 6BCL LOW Density GLYOXAL 4BCL LOW Density GLYOXAL 6BCL
Agarose % 4 6 4 6 4 6
Activation Degree (µmol Glyoxyl/ml gel) - 80-100 40-60 40-60 15-25 15-25
Binding Capacity(1) (mg BSA/ml gel) - 25-30 15-20 20-25 5-10 5-10
Cat. No. - 6BCL-GH1-X* 4BCL-GH1-X* 6BCL-GM3-X* 4BCL-GH0-X* 6BCL-GH0-X*
Antimicrobial Agent 0.5M NaCL containing 0.02% thimerosal or 20% ethanol
Storage Temperature 2-8℃

 

*X: Product Quantity

 

 

 

 High Pressure: GLYOXAL Rapid Run™ Beads

Bead (Geometry, size) Spherical, Standard: ~50 - 150µm Spherical, Fine: ~20 - 50µm
Cross-Linked Highly cross-linked agarose
Matrix Active Groups Agarose with some diols oxidized to aldehydes
Product Name High Density GLYOXAL 4 RAPID RUNTM High Density GLYOXAL 6 RAPID RUNTM LOW Density GLYOXAL 4 RAPID RUNTM LOW Density GLYOXAL 6 RAPID RUNTM High Density GLYOXAL 4 RAPID RUNTM FINE High Density GLYOXAL 6 RAPID RUNTM FINE
Agarose % 4 6 4 6 4 6
Activation Degree (µmol Glyoxyl/ml gel) 40-60 40-60 15-25 15-25 15-25 15-25
Cat. No. 4RR-GH1-X* 6RR-GM3-X* 4RR-GL0-X* 6RR-GL0-X* 4RRF-GL0-X* 6RRF-GL0-X*
Antimicrobial Agent 20% Ethanol
Storage Temperature 2-8℃

 

*X: Product Quantity (25 or 100ml)

 

 

この製品に関するご意見・ご照会・お問合せはこちら

Apollo Scientific社 ブロモ化キノリン誘導体

$
0
0

様々なブロモ化キノリン誘導体を揃えていますApollo_Logo_Stkd_RGB.jpg

 

 

 

 

この製品に関するご意見・ご照会・お問合せはこちら

 

 

Quinoline derivatives are often used in the designs of many synthetic compounds with diverse pharmacological properties. They have antiseptic, antipyretic properties and are used for the preparation of antimalarial drugs. Anticancer activities [1,2] have been studied for many quinoline derivatives. It has been known that quinoline derivatives may act as anticancer agents through a variety of mechanisms with the most common mechanism being the inhibition of tyrosine kinase isozymes [3]. In a recent published study by Ökten et al. [4] 6,8-dibromide and 6,8-dimethoxide quinolines showed promising activities against several tumour cell lines.

The diversity of the substitution on the quinoline ring system offers additional industrial applications such as fungicide, biocides, flavouring agents, corrosion inhibitors and pharmaceuticals.

The presence of halogen atoms allows higher reactivity, therefore the preference given to such compounds by synthetic chemists in performing coupling reactions [5] or metal –halogen exchange reaction [6].

Brominated quinolines contain a key structural component of numerous compounds and bromoquinoline-based derivative synthesis is often restricted due to the difficulty in the preparation of bromoquinoline.

A novel range of “bromo”-containing quinolines and isoquinolines is available from stock in our catalogue.

[1].Heiniger B, Gakhar G, Prasain K, Hua D.H and Nguyen T.A, Anticancer Res. 2010, 30, 3927-3932
[2].Solomon R.V and Lee H, Curr. Med. Chem. 2011, 18, 1488-1508
[3]. Ghorab M.M, Ragab F.A, Heba H.I and Ghorab W.M, J.Het. Chem. 2011, 48(6)
[4].Ökten S, Çakmak O, Erenler R, Yüce Ö and Tekin S, Turk.J.Chem. 2013, 37, 896-908
[5]. Vladimir V, Kouznetosov V.V, Vargas Mendez L.Y, Carlos C.M and Melendez Gomez M, Curr. Org. Chem. 2005, 9, 141
[6].Lindley J, Tetrahedron 1984, 40, 1433-1456

 

ApolloQuinolines1.png

 

 

 ApolloQuinolines2.png

 

 

 

Cat. No. Product Name Size
OR300068 5-Bromo-1-chloroisoquinoline  500mg
OR300092 3-Bromo-6-chloroisoquinoline  500mg
OR300093 3-Bromo-5-chloroisoquinoline  500mg
OR300094 3-Bromo-7-chloroisoquinoline  500mg
OR300095 3-Bromo-8-chloroisoquinoline  500mg
OR300111 1-Bromo-6-chloroisoquinoline  500mg
OR300112 1-Bromo-7-chloroisoquinoline  500mg
OR3097 6-Bromo-2-methylquinoline  5g
OR3617 6-Bromo-4-chloro-2-methylquinoline  500mg
1g
OR3631 6-Bromo-4-hydroxyquinoline  500mg
1g
OR3654 7-Bromo-2-chloroquinoline  500mg
1g
OR60188 8-Bromo-4-hydroxyquinoline 95+%  1g
5g
PC31854 8-Bromo-4-chloro-2-(trifluoromethyl)quinoline  250mg
PC49117 4-Bromo-2-(trifluoromethyl)quinoline  250mg
1g
PC7326 6-Bromo-4-chloro-2-(trifluoromethyl)quinoline  1g

 

 

この製品に関するご意見・ご照会・お問合せはこちら

 

 

CHI SCIENTIFIC社 各種細胞の初代培養キット PrimaCell™

$
0
0

初めての初代培養に最適なキット

 

CHI transparent_logo.png

 

 

 

 

 

 

 

 この製品に関するご意見・ご照会・お問合せはこちら

 

PrimaCell™ kit is complete primary cell culture systems to guide you step-by-step culturing various tissue primary cells of avian, human, mouse and rat. Each PrimaCell™ system is customized for different types of Avian, Mouse, Rat and Human cells and consists of seven components.

Delivering Power & Control in Your Hands
Our PrimaCell™ Kits deliver the ultimate solution for isolating and culturing Primary Cells to give you maximum flexibility and control over your experiments . Our cutting-edge approach saves time and resources so that you can achieve your most ambitious goals faster.

Achieving Your Most Ambitious Goals Faster
Our patented protocol technology and optimized quality reagents give you the freedom to focus on discovering the next breakthrough in biomedical research. Our PrimaCell™ Kits include everything you need to successfully isolate and culture Primary cells from human, mouse, rat, and avian.

PrimaCell™ Kit Components

chi primacell 1.jpg

 

 

 

 

 

 

 

 

 

 

• Optimal Cell-Specific Tissue Dissociation System
• Tissue-Specific  Fibroblast Growth Inhibitors, FibrOut™
• PrimaCell™ Basal Culture Medium
• Growth Factor & Cytokine Supplements
• Highly Purified & Specially Treated Serum
• Proprietary Buffers & Solutions for Tissue Preparation
• Step-by-Step Protocol

 

 この製品に関するご意見・ご照会・お問合せはこちら

PrimaCell Kit Components 

  Optimal Cell-Specific Tissue Dissociation System 

  Tissue-Specific  Fibroblast Growth Inhibitors, FibrOut™ 

  PrimaCell Basal Culture Medium 

  Growth Factor & Cytokine Supplements

  Highly Purified & Specially Treated Serum

  Proprietary Buffers & Solutions for Tissue Preparation

  Step-by-Step Protocol

IBA社 His-tag→Strep-tag変換アダプター His-STREPPER

$
0
0

His-STREPPERはStrep-tag®IIとtrisNTAからなる分子で、Hisタグ融合タンパク質のHis-tag部分にtrisNTAを介して結合することで、タグをStrep-tag®IIへ変換するアダプターとして機能します。His-STREPPERを用いることにより、Hisタグ融合タンパク質をクローニング操作でタグ変換することなく、タンパク質の高純度精製で好評のStrep-tag®/Strep-Tactin®タンパク質発現・精製システムを利用することが可能になります。

 

詳細情報 >>

 

 

この製品に関するご意見・ご照会・お問合せはこちら

 

 

 

メーカー情報

Cat. No. 2-0920-005

His-STREPPER, 500 μg

 

His-STREPPER- the His/Strep-tag®II Adapter - is a molecule comprising Strep-tag®II (SAWSHPQFEK) conjugated with a nickel charged trisNTA (see Fig.1a). It tightly binds to 6xHis-tag and thereby converts a 6xHis-tag fusion protein to a Strep-tag®II fusion protein without the need for cloning. (see Fig.1b)

 

His-STREPPER should be applied to the His-tag fusion protein present in the initial cell lysate or in the His-tag eluate if unsatisfying results from the His-tag elution step are obtained (Note, that imidazole affects binding of His-STREPPER).

 

The resulting Strep-tag fusion protein can be applied to a Strep-Tactin column and further processed according to the Strep-tag purification protocol. (see Fig.1c)

 

Elution of the converted Strep-tag fusion protein can be performed either with imidazole (to elute the His-tag protein without the Adapter) or with desthiobiotin (to elute the Strep-tag protein).

 

His-STREPPER allows His-tag users to benefit from the advantages of the Strep-tag purification system, namely the high purity of the isolated proteins, without a time-consuming cloning process.

 

 

His-STREPPER_Figure1.jpg 

Fig1: His-STREPPER binds to 6xHis-tag fusion proteins and thereby converts them to Strep-tag fusion proteins. These can be purified through Strep-Tactin. 

 

 

His-STREPPER_Figure2.jpg 

Fig2: Purification results for GFP-His using different purification protocols. His-STREPPER: Strep-Tactin provides better results than His-tag:Ni-NTA.

 

詳細情報 >>

 

 

この製品に関するご意見・ご照会・お問合せはこちら


Tocris社 2014年6月新製品

$
0
0

tocris-logo-web.jpg

 

 

 

 

この製品に関するご意見・ご照会・お問合せはこちら

 

 

New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.

 

 

Cat.No. Product Name Activity
5199 AZD 7762 hydrochloride Potent and selective ATP-competitive inhibitor of Chk1 and Chk2
5098 KRCA 0008 Potent Ack1 and ALK dual inhibitor; orally bioavailable
5077 DDR1-IN-1 dihydrochloride Selective DDR1 inhibitor
4888 KHS 101 hydrochloride Selective inducer of neuronal differentiation
5086 PA 452 RXR antagonist
5005 DR 4485 hydrochloride High affinity and selective 5-HT7 antagonist; orally bioavailable
4854 ML 00253764 hydrochloride Melanocortin MC4 receptor antagonist; brain penetrant
4598 PHT 427 Dual Akt and PDK1 inhibitor; antitumor
 

 

この製品に関するご意見・ご照会・お問合せはこちら

Duchefa社 植物マイクロプロパゲーション用容器 SETIS™ Bioreactor

$
0
0
植物のマイクロプロパゲーションに最適な容器!一時的に培地へ浸漬するシステムduchefa logo.jpg

 

 

 

 

 

この製品に関するご意見・ご照会・お問合せはこちら

Plant tissue culture methods have been used for more than 30 years to propagate a large variety of plants. The conventional method, using semisolid (agar) medium, has been widely used because of its simplicity and low costs. However, the huge amount of labor required is a major disadvantage. New technologies have been developed to reduce the handling time, while at the same time increasing the multiplication rates and plant quality. As a result, the Temporary Immersion System (TIS), was created in the 80s.

The principle of TIS technology is simply immersing the plant material into liquid growth media for short periods of time. These immersions are sufficient for the plant’s nutrients uptake. TIS technology profits from the advantages of liquid cultures, while growing the plants under high gas-exchange environments.

 

Duchefa SETIS 1.jpg

 

 

Advantages of TIS technology
- Production of more plants per square meter
- Higher multiplication rates
- Use of liquid medium reduces agar costs
- Higher nutrient uptake
- Reduced manipulations and labor
- Forced aeration increases growth and biomass production
- Improved plant quality
- Automatization

 

Duchefa SETIS 2.jpg

 

There are various TIS bioreactor conformations, which have been described by Etienne & Berthouly (2002). From those, the twin-bottles principle has been the most used in commercial
micropropagation.

The SETIS™ bioreactor is based on this principle, using separated vessels for plant material and growth media, but with an optimized design and technology. SETIS™ is a standard and ready-to-use system for large-scale plant micropropagation.

 

Duchefa SETIS 3.jpg

 

 

The SETIS™ bioreactor and parts
Composed of two vessels:
- Culture vessel (5.6 liters) with ø80mm neck opening.
- Media vessel (4 liters) with ø50mm neck opening.


The culture vessel is positioned on top of the media vessel, making the system very compact and easier to use.
The vessels contain two external hose-barb connectors as part of the vessel body. There are no internal components in the vessels.
The vessels are closed via screw caps (80 and 50 mm diameter), using a silicone gasket in between to assure perfect sealing.
The culture vessel has a flat bottom area of 432 cm2, allowing a high capacity and optimal plant material distribution.
External measurements assembled: 308x180x250 mm
Base measurement: 240x180 mm
The bioreactor requires horizontal shelving for optimal drainage. The inclination of the culture vessel allows self-drainage using gravity. A maximum of 3 liters of growth medium is completely
drained in approximately 5 min.
Working air pressure: 0.1-0.3 bar
The capacity of the bioreactor depends on the plant species, ranging from 300 to 1200 plants per bioreactor.
All components (vessel opening, connectors and air filters), are located on the front side of the bioreactor, simplifying access once placed on the shelf.

 

The bioreactor includes stackable elements between both vessels to assure a perfect positioning of the culture vessel on top of the media vessel, and to avoid its diaplacement during operation.
Two handles are positioned at both sides of the media vessel to easily carry the assembled bioreactor.
The bioreactor is composed of only three materials, polycarbonate (vessels), polypropylene (screw caps and air filters) and silicone (gaskets and tubing). All of these materials withstand autoclave sterilization and gamma irradiation.
The design of the bioreactor, with its free and curved top, and the high transparency of the vessels, allows a maximum light incidence into the plants.
Note: Follow the instructions described in “User Manual” (www.setis-systems.be), for proper bioreactor utilization.

 

Cultivating different plant species
The SETIS™ bioreactor has been used to successfully cultivate many different plant species, such as sugarcane, banana, potato, eucalyptus, paulownia and orchids.
With its adequate culture volume, optimal light entry, complete drainage and improved ventilation, the SETIS™ bioreactor is an ideal system to avoid vitrification problems and increase plant quality.

 

Duchefa SETIS 4.jpg

 

SETIS™ is more than a bioreactor
The concept of providing an optimized bioreactor to the plant micropropagation industry is not everything.
Additionally, there is a range of products and services offered under the SETIS™ brand name, such as bioreactor accessories, side equipments and technology transfer.

 

Duchefa SETIS 5.jpg

 

SETIS™ comprises all necessary elements for designing and initiating a high-tech Temporary Immersion System laboratory.


Advantages of the SETIS™ bioreactor
• Simple and minimalist
• Compact
• Secure
• Maximum surface utilization
• Easy assembly and handling
• Optimal lab setup
• Standard
• Ready-to-use

 


 

 

Duchefa SETIS 6.jpg

 

この製品に関するご意見・ご照会・お問合せはこちら

Norgen社 血漿・血清中のRNA精製キット

$
0
0

迅速かつ簡単に遊離RNAおよびエキソソームRNAの精製が可能

norgen-biotek.jpg

 

 

 

 この製品に関するご意見・ご照会・お問合せはこちら

 

Kit Specifications
Minimum Plasma/Serum Input 50 μL
Maximum Plasma/Serum Input 200 μL
Time to Complete Purification 15-20 minutes
Size of RNA Purified All sizes, including miRNA and small RNA (< 200 nt)

 

 

Plasma/Serum RNA Purification Kit Benefits
No phenol:chloroform extractions Circulating RNA and Exosomal RNA is isolated without the use of harmful chemicals such as phenol or chloroform
Isolate all sizes of circulating RNA and exosomal RNA The kit allows for the isolation of all sizes of fragmented circulating RNA and exosomal RNA, including microRNA
Fast and easy processing Rapid spin column format allows for the processing of multiple sam-ples in under 15-20 minutes.
Small input volume Isolate circulating RNA and exosomal RNA from 50 μL to 200 μL of plasma/serum.
Concentrate circulating RNA and Exosomal RNA Circulating and exosomal RNA present in input volumes of 50 μL to 200 μL are concentrated into final elution volume of 10 μL to 25 μL.
Isolate inhibitor-free RNA Purified RNA can be used in a number of sensitive downstream ap-plications including reverse transcription qPCR, reverse transcription PCR, Northern blotting, RNase protection and primer extension, and expression array assays

 

 

Applications

The purified circulating RNA is compatible with most of the molecular biological applications such as:

  • Reverse transcription qPCR
  • Reverse transcription PCR
  • Northern blotting
  • RNase protection and primer extension
  • Expression array assays.
  • miRNA array
  • RNA-Seq
  • Nanostring
  • Fluidigm
  • Droplet/Digital PCR

 

 

 NorgenGraph1.png

 

Figure 1. Effective and Consistent Detection of miRNA from Plasma. Norgen's Plasma/Serum RNA Purification Kit can effectively isolate miRNA from plasma. Circulating miRNA was isolated from 200 µL plasma using Norgen's Plasma/Serum RNA Purification Kit, Company A's kit and Company C's kit. Circulating miRNA was isolated from 600 µL using Company B's Kit. Stem loop RT-qPCR using primers specific to miR-21 was performed. In brief, 1 microliter of the 15 µL purified RNA using Norgen's Plasma/Serum RNA Purification Kit, Company A's kit and 3.3 microliters of the 50 µL purified RNA using Company C's kit and Company B's kit was then subjected to a 20 µL reverse transcription using miR-21 stem-loop reverse primer. Three microliters of the reverse transcription was used in a 20 µL real-time PCR reaction with primers to detect the human miR-21. Norgen's Plasma/Serum RNA Purification Kit is the only product that showed the most consistent and the highest recovery of the miR-21 transcripts as compared to the other isolation methods. The recovery of the miRNA from 200µL plasma was higher than that recovered from RNA purified from 600µL using Company B's kit.

 

 

plasmaserum_rna_purification_kit-55000-figure1.jpg

Figure 2. Purification of Circulating RNA from Different Plasma Volumes. Norgen’s Plasma/Serum RNA Purification Kit was used to purify circulating RNA from 50µL, 100µL and 200µL plasma prepared from blood collected on EDTA. Three microlitres of the purified RNA was then used as the template in RT-qPCR reactions to detect miR-21 (Figure 1A) and the housekeeping 5S rRNA transcript (Figure 1B). The relative amount of both the miR-21 (Figure 1A) and the 5S rRNA transcript (Figure 1B) is linearly increasing with increasing the sample input volume.

 

 

plasmaserum_rna_purification_kit-55000-figure2.jpg

Figure 3. Eluting Purified Circulating RNA from into Different Elution Volumes. Norgen’s Plasma/Serum RNA Purification Kit was used to purify circulating RNA from 200µL plasma prepared from blood collected on EDTA and eluted in 10µL, 15µL, and 25µL. Three microlitres of the purified RNA was then used as the template in RT-qPCR reactions to detect miR-21 (Figure 2A) and the housekeeping 5S rRNA transcript (Figure 2B). The relative amount of both the miR-21 (Figure 1A) and the 5S rRNA transcript (Figure 1B) is decreasing with increasing the elution volume indicating the efficient concentration of the plasma circulating RNA in a very low elution volume.  

 

 

Item Cat. No. Kit Size
Plasma/Serum RNA Purification Kit 55000 50 preps

 

 

この製品に関するご意見・ご照会・お問合せはこちら

B'SYS社 イオンチャネル安定発現細胞株

$
0
0

バリデーション済み!パッチクランプ法等を用いたスクリーニングに最適な細胞株

BSYS logo.gif

 

 

 

 

 

 

 

この製品に関するご意見・ご照会・お問合せはこちら

All recombinant ion channel targets are fully validated and available for screening purposes. B‘SYS continuously expands its library of ion channels. 

TargetGeneDisorderCell TypeExpression
hERG KCNH2 LQT Syndrome 2 HEK 293 inducible
hERG KCNH2 LQT Syndrome 2 HEK 293 constitutive
hERG KCNH2 LQT Syndrome 2 CHO inducible
hERG KCNH2 LQT Syndrome 2 CHO constitutive
hERG Duo KCNH2 LQT Syndrome 2 CHO constitutive
KVLQT1/minK KCNQ1/KCNE1 LQT Syndrome 1/5 HEK 293 inducible
KVLQT1/minK KCNQ1/KCNE1 LQT Syndrome 1/5 CHO constitutive
NaV1.5 SCN5A LQT Syndrome 3 CHO constitutive
NaV1.5 duo
SCN5A LQT Syndrome 3 CHO constitutive
NaV1.3 SCN3A Epilepsy / Pain CHO constitutive
GlyRα3 (h)
GLRA3 Pain sensation HEK 293 inducible
GlyRα3 (r) GLRA3 Pain sensation CHO constitutive
TRPV1 TRPV1 (VR1) - CHO constitutive
TRPV3 TRPV3 Olmsted syndrom CHO constitutive
TRPV3 TRPV3 Olmsted syndrom HEK 293 inducible
TRPV4 TRPV4 Dwarfism, Neuropathy CHO constitutive
TRPV4 TRPV4 Dwarfism, Neuropathy HEK 293 inducible
TRPM8 TRPM8 Pain sensation HEK 293 constitutive
TRPM8 TRPM8 Pain sensation CHO constitutive
KV1.1 KCNA1 Seizure disorders CHO constitutive
KV1.2 KCNA2 Seizure disorders CHO constitutive
KV1.3 KCNA3 Immune system related CHO constitutive
KV1.4 KCNA4 - CHO constitutive
KV1.5 KCNA5 Heart function CHO constitutive
KV1.6 KCNA6 - CHO constitutive
KV2.2 KCNB2 - CHO constitutive
KV2.2 KCNB2 - HEK 293 inducible
KV7.2 KCNQ2 Epilepsy CHO constitutive
KV4.3 KCND3 - CHO constitutive
KV4.3 Chip KCND3 - CHO constitutive
KV7.3 KCNQ3 Epilepsy
CHO
constitutive
Kir2.1 KCNJ2 LQT Syndrome CHO constitutive
VDAC VDAC1 -
CHO constitutive
P2X4 P2rx4 - HEK 293 constitutive
P2X7 P2rx7 - HEK 293 constitutive
PEPT1 SLC15A1 - MDCK constitutive
Stargazin CACNG2 Seizure disorders
HEK 293 constitutive
ASIC1a ACCN2 - CHO constitutive
ASIC1b ACCN2 - CHO constitutive
ASIC3 ACCN3 - CHO constitutive
NMDA GRIN1/GRIN2A Epilepsy HEK 293 inducible
NMDA GRIN1/GRIN2B Depression
HEK 293 inducible
NMDA GRIN1/GRIN2D - HEK 293 inducible
NMDAR1 GRIN1 Mental retardation CHO inducible

 

 

この製品に関するご意見・ご照会・お問合せはこちら

Santa Cruz社 モノクローナル抗体 2014年5月新製品

$
0
0

Santa Cruz社 モノクローナル抗体 2014年5月新製品

Santa Cruz社では、シグナル中間体、転写因子、合成と分解などさまざまな研究対象のモノクローナル抗体を新発売しました。

 

 

新製品一覧

容量:200μg/ml  価格:51,000円

用途:Western Blotting, Immunoprecipitation, Immunofluorescence, ELISA

略号:Av=Avian(Bird), Bov=Bovine(Cow), Ca=Canine, Hs=Horse(Equine), Hu=Human, Ms=Mouse, Por=Porcine(Pig, Swine), Rt=Rat

製品名交差性抗原アイソタイプメーカー製品番号オンライン
カタログへ
構造タンパク質
CKAP2 (B-12) Hu 431-494 (Hu) mouse IgG1 sc-398286 e-Nacalai.jpg
CLAMP (G-3) Ms, Rt, Hu 3-19 (Hu) mouse IgG1 sc-398342 e-Nacalai.jpg
emerin (F-11) Hu > Ms, Rt 196-223 (Hu) mouse IgG1 sc-398278 e-Nacalai.jpg
Keratin 25 (B-2) Hu 60-81 (Hu) mouse IgG2b sc-398320 e-Nacalai.jpg
KLC3 (E-7) Ms, Rt, Hu, Bov 171-192 (Hu) mouse IgG1 sc-398332 e-Nacalai.jpg
Odf3l2 (H-4) Hu 5-34 (Hu) mouse IgG1 sc-398309 e-Nacalai.jpg
TEX10 (B-9) Hu 23-322 (Hu) mouse IgG1 sc-398384 e-Nacalai.jpg
合成と分解
ACSL5 (E-12) Ms, Rt, Hu 73-104 (Hu) mouse IgG1 sc-398310 e-Nacalai.jpg
ARD (H-3) Ms, Rt, Hu 52-69 (Hu) mouse IgM sc-398325 e-Nacalai.jpg
CA III (B-2) Ms, Rt, Hu 224-247 (Hu) mouse IgG1 sc-398369 e-Nacalai.jpg
CMAS (E-8) Ms, Rt, Hu, Hs, Ca, Bov, Por 150-163 (Hu) mouse IgG1 sc-398296 e-Nacalai.jpg
Gastric Lipase (B-2) Hu 301-326 (Hu) mouse IgG3 sc-398343 e-Nacalai.jpg
GPI (A-5) Hu 1-300 (Hu) mouse IgG1 sc-398381 e-Nacalai.jpg
GPI (E-4) Hu 1-300 (Hu) mouse IgG2b sc-398382 e-Nacalai.jpg
HIBADH (D-11) Hu 1-157 (Hu) mouse IgG1 sc-398288 e-Nacalai.jpg
LCAT (B-4) Ms 328-387 (Ms) mouse IgG2a sc-398361 e-Nacalai.jpg
PBGS (E-10) Ms, Rt, Hu 142-159 (Hu) mouse IgG1 sc-398308 e-Nacalai.jpg
PCSK1N (D-11) Ms, Rt 47-69 (Ms) mouse IgG1 sc-398295 e-Nacalai.jpg
PSMD12 (H-3) Hu, Hs, Ca, Bov, Por 1-300 (Hu) mouse IgG1 sc-398279 e-Nacalai.jpg
UBE2S (F-10) Ms, Rt, Hu, Hs, Ca, Bov 1-22 (Hu) mouse IgG1 sc-398339 e-Nacalai.jpg
神経生物学
DARPP-32 (G-5) Ms, Bov 134-195 (Bov) mouse IgG2a sc-398360 e-Nacalai.jpg
Fe65 (F-6) Hu 1-150 (Hu) mouse IgG1 sc-398389 e-Nacalai.jpg
Iba1/2 (F-4) Hu 1-147 (Hu) mouse IgG3 sc-398406 e-Nacalai.jpg
MYT1 (B-10) Hu 538-684 (Hu) mouse IgG1 sc-398299 e-Nacalai.jpg
輸送関連タンパク質
GRASP65 (B-3) Ms, Rt, Hu 2-29 (Hu) mouse IgG2a sc-398363 e-Nacalai.jpg
IFT172 (A-11) Hu 1353-1652 (Hu) mouse IgG1 sc-398393 e-Nacalai.jpg
NASP (A-6) Hu 489-788 (Hu) mouse IgG1 sc-398379 e-Nacalai.jpg
ORP-3 (D-12) Ms, Rt, Hu 480-519 (Hu) mouse IgG2a sc-398326 e-Nacalai.jpg
SPCA2 (B-5) Hu 941-962 (Hu) mouse IgG1 sc-398330 e-Nacalai.jpg
USE1 (D-1) Hu 1-78 (Hu) mouse IgG1 sc-398316 e-Nacalai.jpg
キナーゼとホスファターゼ
ACP1α (G-9) Ms, Rt, Hu 44-69 (Hu) mouse IgG1 sc-398377 e-Nacalai.jpg
ACYP2 (B-3) Hu 1-99 (Hu) mouse IgG2b sc-398298 e-Nacalai.jpg
DRAK2 (C-2) Hu 256-372 (Hu) mouse IgG1 sc-398324 e-Nacalai.jpg
GAP1-InsP4 BP (E-9) Ms, Rt, Hu, Hs, Ca, Bov, Por, Av 103-136 (Hu) mouse IgG2a sc-398283 e-Nacalai.jpg
GK1 (E-4) Ms, Rt, Hu, Hs, Por 13-31 (Hu) mouse IgG2a sc-398385 e-Nacalai.jpg
GRK 7 (C-2) Hu 472-501 (Hu) mouse IgM sc-398371 e-Nacalai.jpg
KPI-2 (D-11) Hu 15-148 (Hu) mouse IgG1 sc-398396 e-Nacalai.jpg
MTMR3 (G-2) Ms, Rt, Hu, Hs, Ca, Bov, Por 1173-1198 (Hu) mouse IgG1 sc-398353 e-Nacalai.jpg
p38α (D-5) Ms, Rt, Hu, Ca, Bov, Por 2-31 (Ms) mouse IgG1 sc-398305 e-Nacalai.jpg
PHYHD1 (B-6) Ms, Hu 1-56 (Hu) mouse IgG1 sc-398378 e-Nacalai.jpg
TBK1 (A-6) Ms, Hu 355-729 (Ms) mouse IgG1 sc-398366 e-Nacalai.jpg
腫瘍抑制因子 / アポトーシス
53BP2 (H-4) Hu, Hs, Ca, Bov, Por 2-19 (Hu) mouse IgG2b sc-398311 e-Nacalai.jpg
BLU (G-10) Hu 9-206 (Hu) mouse IgG1 sc-398350 e-Nacalai.jpg
Mammaglobin A (D-7) Hu 31-56 (Hu) mouse IgG1 sc-398405 e-Nacalai.jpg
Neurofibromin (E-8) Hu, Hs, Ca, Bov, Por, Av 507-530 (Hu) mouse IgG1 sc-398267 e-Nacalai.jpg
NOD1 (F-6) Ms, Rt, Hu 707-730 (Hu) mouse IgG2a sc-398398 e-Nacalai.jpg
p-PTEN (H-3) Ms, Rt, Hu, Ca, Por, Av Ser 380 (Hu) mouse IgG1 sc-377573 e-Nacalai.jpg
TIAR (G-6) Ms, Rt, Hu 348-377 (Hu) mouse IgG2b sc-398372 e-Nacalai.jpg
TIAR (H-1) Ms, Rt, Hu, Hs, Ca, Bov, Por 348-377 (Hu) mouse IgG2a sc-398373 e-Nacalai.jpg
シグナル中間体
αA-crystallin (H-4) Ms, Rt, Hu 107-138 (Hu) mouse IgG1 sc-398304 e-Nacalai.jpg
αC-crystallin (H-5) Hu 24-88 (Hu) mouse IgG1 sc-398395 e-Nacalai.jpg
Cbl (G-12) Hu 607-906 (Hu) mouse IgG1 sc-398282 e-Nacalai.jpg
EWS (B-1) Ms, Rt, Hu, Ca, Bov, Por 628-656 (Hu) mouse IgG2b sc-398318 e-Nacalai.jpg
FNBP2 (G-10) Ms, Rt, Hu 1038-1060 (Hu) mouse IgG1 sc-398399 e-Nacalai.jpg
GPT2 (G-7) Ms, Hu 378-417 (Hu) mouse IgG2a sc-398383 e-Nacalai.jpg
HspBP1 (E-3) Hu 63-241 (Hu) mouse IgG1 sc-398319 e-Nacalai.jpg
Junctophilin-2 (A-1) Ms, Rt, Hu 543-579 (Hu) mouse IgG2b sc-398290 e-Nacalai.jpg
LRG1 (C-5) Ms 213-257 (Ms) mouse IgG2b sc-398301 e-Nacalai.jpg
MIRAB13 (F-3) Hu 743-804 (Hu) mouse IgG1 sc-398397 e-Nacalai.jpg
MTO1 (H-5) Ms, Rt, Hu, Hs, Ca, Bov 267-282 (Hu) mouse IgG1 sc-398386 e-Nacalai.jpg
NDRG1 (B-5) Ms, Rt, Hu 2-29 (Hu) mouse IgG1 sc-398291 e-Nacalai.jpg
NUBP1 (C-3) Ms, Rt, Hu, Hs, Ca, Bov, Por, Av 230-263 (Hu) mouse IgG2b sc-398368 e-Nacalai.jpg
RGS4 (H-12) Ms, Rt, Hu 182-205 (Hu) mouse IgM sc-398348 e-Nacalai.jpg
RSHL1 (C-4) Hu 51-199 (Hu) mouse IgG2a sc-398329 e-Nacalai.jpg
RSHL1 (C-9) Hu 51-199 (Hu) mouse IgG1 sc-398317 e-Nacalai.jpg
SEMA6A (B-3) Hu 571-750 (Hu) mouse IgG1 sc-398302 e-Nacalai.jpg
Shc (H-11) Hu 366-473 (Hu) mouse IgG2a sc-398289 e-Nacalai.jpg
SKAP55-R (C-9) Hu 142-267 (Hu) mouse IgG2b sc-398285 e-Nacalai.jpg
STCH (A-11) Hu 49-150 (Hu) mouse IgG1 sc-398297 e-Nacalai.jpg
Vinexin (D-4) Hu 206-243 (Hu) mouse IgG2b sc-398275 e-Nacalai.jpg
VPS33B (G-9) Hu 271-570 (Hu) mouse IgG1 sc-398322 e-Nacalai.jpg
VPS54 (B-4) Ms, Rt, Hu, Hs, Ca, Bov, Por 917-944 (Hu) mouse IgG2a sc-398300 e-Nacalai.jpg
WAP (A-9) Ms > Rt 63-89 (Ms) mouse IgM sc-398341 e-Nacalai.jpg
WAP (E-8) Ms > Rt 60-89 (Ms) mouse IgG2a sc-398276 e-Nacalai.jpg
WDR70 (C-5) Hu 355-654 (Hu) mouse IgG2a sc-398268 e-Nacalai.jpg
WIPI-4 (G-12) Ms, Rt, Hu, Hs, Ca, Bov, Por 124-149 (Hu) mouse IgG1 sc-398272 e-Nacalai.jpg
ZP3 (G-1) Hu 23-322 (Hu) mouse IgG1 sc-398359 e-Nacalai.jpg
細胞膜受容体
CRLF3 (D-10) Hu 3-242 (Hu) mouse IgG1 sc-398388 e-Nacalai.jpg
EDAR (F-5) Hu 61-360 (Hu) mouse IgG1 sc-398337 e-Nacalai.jpg
p-gp130 (A-12) Ms, Rt, Hu, Hs Ser 782 (Hu) mouse IgG2a sc-377572 e-Nacalai.jpg
転写因子
ARA160 (C-10) Hu 811-1093 (Hu) mouse IgG1 sc-398411 e-Nacalai.jpg
ARID3A (A-4) Hu 565-592 (Hu) mouse IgG1 sc-398367 e-Nacalai.jpg
BTEB2 (B-8) Ms, Hu 167-286 (Hu) mouse IgG1 sc-398409 e-Nacalai.jpg
CASZ1 (B-11) Ms, Rt, Hu 913-926 (Hu) mouse IgG2b sc-398303 e-Nacalai.jpg
CGGBP1 (G-12) Ms, Rt, Hu, Por 77-99 (Hu) mouse IgG3 sc-398347 e-Nacalai.jpg
ERF (E-9) Hu 428-495 (Hu) mouse IgG1 sc-398269 e-Nacalai.jpg
EXOSC6 (D-10) Ms, Rt, Hu 29-52 (Hu) mouse IgG1 sc-398277 e-Nacalai.jpg
FIP1L1 (C-10) Hu, Hs, Ca, Bov, Por 46-212 (Hu) mouse IgG1 sc-398392 e-Nacalai.jpg
HBO1 (G-2) Hu, Hs, Ca, Bov, Por 20-47 (Hu) mouse IgG2b sc-398346 e-Nacalai.jpg
HEXIM2 (B-9) Ms 1-90 (Ms) mouse IgG2a sc-398355 e-Nacalai.jpg
HLTF (G-6) Hu 923-1009 (Hu) mouse IgG1 sc-398357 e-Nacalai.jpg
Ikaros (E-2) Hu 1-100 (Hu) mouse IgG2a sc-398265 e-Nacalai.jpg
JRK (E-9) Hu 49-187 (Hu) mouse IgG1 sc-398356 e-Nacalai.jpg
POLR1E (C-11) Hu 8-113 (Hu) mouse IgG2a sc-398270 e-Nacalai.jpg
PPAN (C-7) Hu 422-445 (Hu) mouse IgG1 sc-398273 e-Nacalai.jpg
RNF152 (B-3) Hu 65-130 (Hu) mouse IgG2a sc-398390 e-Nacalai.jpg
RNF152 (F-4) Hu 65-130 (Hu) mouse IgG1 sc-398407 e-Nacalai.jpg
RNF152 (F-6) Hu 65-130 (Hu) mouse IgG2b sc-398391 e-Nacalai.jpg
SCML2 (C-7) Hu 630-651 (Hu) mouse IgG2a sc-398400 e-Nacalai.jpg
Suppressin (C-8) Ms, Rt, Hu, Hs, Ca, Por, Av 119-134 (Hu) mouse IgG3 sc-398387 e-Nacalai.jpg
TSEN54 (A-9) Ms, Rt, Hu, Hs, Ca, Bov 111-128 (Hu) mouse IgG2b sc-398327 e-Nacalai.jpg
YB-1 (C-3) Hu 196-240 (Hu) mouse IgG2a sc-398340 e-Nacalai.jpg
成長因子とホルモン
ephrin-A3 (G-11) Hu 149-238 (Hu) mouse IgG1 sc-398331 e-Nacalai.jpg
FGF-15 (G-5) Ms, Rt 88-105 (Ms) mouse IgG2b sc-398338 e-Nacalai.jpg
GDF-8/11 (A-1) Ms, Rt, Hu, Hs, Ca, Bov, Por, Av 258-270 (Hu) mouse IgG2b sc-398333 e-Nacalai.jpg
HDGF (H-3) Hu 121-168 (Hu) mouse IgG1 sc-398344 e-Nacalai.jpg
IL-5 (B-2) Ms, Rt > Hu 36-63 (Ms) mouse IgG2a sc-398334 e-Nacalai.jpg
TSG-6 (D-4) Ms, Rt, Hu 22-51 (Hu) mouse IgG1 sc-398307 e-Nacalai.jpg
リンパ球シグナル伝達
B7-H3 (C-1) Ms, Rt, Hu, Ca, Bov 82-107 (Hu) mouse IgG2b sc-398323 e-Nacalai.jpg
B7-H3 (G-12) Ms, Rt, Hu, Ca, Bov 82-107 (Hu) mouse IgG1 sc-398403 e-Nacalai.jpg
CD84 (E-3) Hu 201-328 (Hu) mouse IgG1 sc-398321 e-Nacalai.jpg
GAPT (B-6) Hu 84-135 (Hu) mouse IgG1 sc-398293 e-Nacalai.jpg
GAPT (H-8) Hu 84-135 (Hu) mouse IgG2a sc-398271 e-Nacalai.jpg
HIP-55 (E-5) Hu 100-186 (Hu) mouse IgG1 sc-398358 e-Nacalai.jpg
HIP-55 (F-9) Hu 100-186 (Hu) mouse IgG2a sc-398351 e-Nacalai.jpg
NAPRT (B-8) Ms, Rt, Hu 141-162 (Hu) mouse IgG2a sc-398404 e-Nacalai.jpg
PLUNC (C-5) Ms 41-80 (Ms) mouse IgG1 sc-398376 e-Nacalai.jpg
PLUNC (G-7) Ms 41-80 (Ms) mouse IgG2b sc-398364 e-Nacalai.jpg
PSGL-1 (C-9) Hu 373-406 (Hu) mouse IgG2a sc-398402 e-Nacalai.jpg
GDP / GTP結合タンパク質
ARL4 (B-10) Ms, Rt, Hu, Ca, Bov, Por 137-196 (Hu) mouse IgG2a sc-398352 e-Nacalai.jpg
Rab 3 GAP p130 (B-8) Hu 935-981 (Hu) mouse IgG1 sc-398354 e-Nacalai.jpg
Rab 3 GAP p150 (B-9) Hu, Hs 64-173 (Hu) mouse IgG1 sc-398315 e-Nacalai.jpg
Rab 3 GAP p150 (H-7) Hu, Hs 64-173 (Hu) mouse IgG1 sc-398314 e-Nacalai.jpg
Rab 7L1 (D-8) Ms, Rt, Hu 118-147 (Hu) mouse IgG2b sc-398274 e-Nacalai.jpg
細胞接着タンパク質
AF-6 (G-7) Ms, Rt, Hu 1565-1592 (Hu) mouse IgM sc-398370 e-Nacalai.jpg
CTNNBL1 (A-11) Hu, Ca 264-563 (Hu) mouse IgG2a sc-398336 e-Nacalai.jpg
CTNNBL1 (D-2) Hu, Ca 264-563 (Hu) mouse IgG1 sc-398335 e-Nacalai.jpg
PCM1 (G-6) Hu 1-262 (Hu) mouse IgG1 sc-398365 e-Nacalai.jpg
R-cadherin (D-9) Ms, Rt, Hu, Ca, Bov 190-223 (Hu) mouse IgG2a sc-398306 e-Nacalai.jpg
チャネルタンパク質
KVβ.2 (H-5) Ms, Rt, Hu, Hs, Ca, Bov, Por, Av 232-249 (Hu) mouse IgA sc-398362 e-Nacalai.jpg
SorCS2 (A-10) Hu 755-1012 (Hu) mouse IgG2a sc-398412 e-Nacalai.jpg
TRPV5 (B-8) Ms, Rt 626-723 (Rt) mouse IgG2a sc-398345 e-Nacalai.jpg
ステロイド受容体
NR5A2 (E-9) Ms, Rt, Hu 2-15 (Ms) mouse IgM sc-398349 e-Nacalai.jpg
PPARα (H-2) Hu 1-98 (Hu) mouse IgG2a sc-398394 e-Nacalai.jpg
細胞周期タンパク質
Cdc40 (H-12) Ms, Rt, Hu 139-162 (Hu) mouse IgG3 sc-398281 e-Nacalai.jpg
Cdc5L (D-11) Hu 503-802 (Hu) mouse IgG1 sc-398280 e-Nacalai.jpg
R2 (A-5) Ms, Rt, Hu, Ca 30-56 (Hu) mouse IgG1 sc-398294 e-Nacalai.jpg
その他
C6orf106 (F-8) Hu 1-298 (Hu) mouse IgG2b sc-398380 e-Nacalai.jpg
DENND2D (H-6) Ms, Rt, Hu, Por 208-233 (Hu) mouse IgG3 sc-398374 e-Nacalai.jpg
DTWD1 (E-5) Ms, Rt, Hu 27-52 (Hu) mouse IgG1 sc-398408 e-Nacalai.jpg
E230008N13Rik (G-10) Ms 1-32 (Ms) mouse IgM sc-398312 e-Nacalai.jpg
FAM63A (F-3) Hu 157-205 (Hu) mouse IgG1 sc-398287 e-Nacalai.jpg
FAM98B (B-1) Ms, Rt, Hu 65-86 (Hu) mouse IgM sc-398375 e-Nacalai.jpg
LOC221710 (E-6) Hu 64-91 (Hu) mouse IgG2a sc-398401 e-Nacalai.jpg
MBLAC2 (A-4) Ms, Rt, Hu, Bov, Por 84-103 (Hu) mouse IgG1 sc-398284 e-Nacalai.jpg
SCYL3 (G-8) Ms, Hu 141-265 (Hu) mouse IgG2a sc-398328 e-Nacalai.jpg
CorA-like Mg2+ transporter protein (A-9) Streptococcus equi subsp. equi 4047 1-273 (Streptococcus equi subsp. equi 4047) mouse IgG1 sc-398313 e-Nacalai.jpg
Metal ABC transporter substrate-binding lipoprotein (C-1) Streptococcus equi subsp. equi 4047 1-310 (Streptococcus equi subsp. equi 4047) mouse IgG1 sc-398266 e-Nacalai.jpg
Orc2 (C-5) y 611-622 (Saccharomyces cerevisiae) mouse IgG2a sc-398410 e-Nacalai.jpg

※記載の内容は、'14年6月現在の情報に基づいております。

Viewing all 1104 articles
Browse latest View live